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Abstract
The purpose of this investigation was to evaluate the effect of six weeks of inspiratory
muscle training (IMT) on heart rate variability (HRV) in young and older adults. Twelve
young (age 22.25 + 2.13 years) and 14 older adults (age 72.5 + 6.44 years) participated in the
study. The training protocol included using IMT device set at a resistance equivalent to 80%
of maximal inspiratory pressure (MIP), five days per week. HRV data were obtained by
electrocardiogram prior to and following six weeks of IMT, along with pulmonary function
measures (vital capacity, forced expiratory volume in one second, maximal ventilatory
volume). The HRV variables included total power (TP), very low frequency (VLF), low
frequency (LF), and high frequency (HF) powers. In addition, normalized LF (LFnu),
normalized HF (HFnu) and LF to HF ratio (LF/HF) were analyzed. The results from the
young group demonstrated a significant increase in HFnu (pre 0.22 + 0.039, post 0.243 +
0.059 nu, p < 0.05), and a significant decrease in LFnu (pre 0.779 + 0.039, post 0.756 +
0.059 nu, p < 0.05) and LF/HF (pre 3.651 + 0.756, post 3.278 + 0.787, p < 0.05). In the older
group, HFnu decreased significantly (pre 0.236 + 0.076, post 0.205 + 0.03 nu, p < 0.05)
along with significant increases in LFnu (0.763 + 0.076, post 0.794 + 0.03 nu, p < 0.05) and
LF/HF (pre 3.551 + 1.08, post 3.94 + 0.574, p < 0.05). No significant change was observed
in any of TP, LF or HF. Both the groups demonstrated a significant increase in inspiratory
muscle strength as determined by MIP (Young: pre 1.06 + 0.33, post 1.68 + 0.38; Older: pre
0.72 + 0.24 cm, post 0.98 + 0.14 cmH2O) (p < 0.05) and the pulmonary function measures.
The results of this study demonstrated that IMT had a training effect on not only inspiratory
muscle strength but also HRV. However, the training response varied within groups. The
young group demonstrated a shift in autonomic balance towards parasympathetic
modulation, while the older group demonstrated decrease in parasympathetic modulation.
iv
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Chapter I
The Problem and Its Scope
Introduction
It has been well established that heart rate (HR), measured as the time between
successive heart contractions (R-R intervals), normally fluctuates at rest (Pagani et al., 1986).
These variations over time between consecutive heart beats are quantified by heart rate
variability (Rajendra, Paul, Kannathal, Lim, & Suri, 2006). The Task force of the European
Society of Cardiology and the North American Society of Pacing and Electrophysiology
(Malik et al, 1996) defined heart rate variability (HRV) as the oscillation in the interval
between consecutive heart beats as well as oscillation between consecutive instantaneous
heart rates.
HRV is a simple and powerful non-invasive tool to investigate autonomic nervous
system (ANS) activity and cardiac autonomic control in particular (Akselrod et al., 1981;
Montano, Cogliati, Dias da Silva, Gnecchi-Ruscone, & Malliani, 2001; Pomeranz et al.,
1985; Rajendra et al., 2006). It reflects the interaction of the sympathetic and
parasympathetic nervous systems to control heart rate (Akselrod et al., 1981; Pagani et al.,
1986). Thus, HRV is widely used to investigate sympathetic- parasympathetic autonomic
balance. HRV is associated with pathogenesis in various clinical conditions, and analysis of
heart rate variability is vital in surveillance of these conditions (van Ravenswaaij-Arts,
Kollee, Hopman, Stoelinga, & van Geijn, 1993).
A reduced HRV has been identified as a strong predictor of risk related to adverse
events in healthy individuals and patients with a large number of diseases. This reflects the
vital role that ANS plays in maintaining health. High heart rate variability is a sign of good
adaptability which implies a healthy individual with well functioning autonomic control

mechanisms. An attempt to improve and possibly correct autonomic imbalance will
substantially decrease mortality (Kleiger, Miller, Bigger, & Moss, 1987). There are several
studies that have investigated the effects of external mitigating factors such as exercise,
relaxation, meditation and breathing patterns, in an attempt to improve HRV. Respiration is
a powerful modulator of heart rate variability, baroreflex and chemoreflex sensitivity
(Bernardi, Porta, Gabutti, Spicuzza, & Sleight, 2001). Respiratory activity is also known to
influence heart rate through both anatomical and physiological mechanisms. There are
studies that have observed favorable effects of different breathing patterns and yoga exercises
on HRV. It is reasonable to suggest that manipulation of respiration may prove to be helpful
in the HRV profile derangement. Inspiratory muscle training (IMT), as its name suggests, is
a form of resistance training for inspiratory muscles. IMT may provide an option to
manipulate the respiratory function and the related physiological mechanisms affecting heart
rate. It is proposed that IMT may also have an effect on cardiovascular regulation and
therefore HRV.
Purpose of the Study
The purpose of this study was to determine the effect of six weeks of IMT on HRV
variables in young (age 18 to 30 years) and older adults (age > 60 years). The HRV analysis
included measurements by frequency domain method before and after the training program.
The variables measured were total power (TP), high frequency power (HF), and low
frequency power (LF). Additionally, LF and HF were expressed in normalized units as LFnu
and HFnu which represent their values relative to total power. LF to HF ratio (LF/HF) was
determined to evaluate sympathovagal balance. The study also investigated the differences
between the two groups in their response to IMT in terms of the changes in HRV variables.
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Hypotheses
The null hypothesis is that there will be no significant difference between pre- and
post measures of HRV after six weeks of IMT training. Additionally, it is hypothesized that
both the young and old groups will exhibit a similar response to training.
Significance of the Study
Most of literature on IMT is restricted to its application in improving respiratory
dynamics in health and disease. Further, it has been shown to be effective in sports and
performance. However, the studies that examined the effects of IMT on the autonomic
nervous system are very limited. This study is relevant as it allows for further investigation
into whether IMT can enhance HRV variables and thereby cardiac autonomic control. This
study also explores differences, if any, in young and old adults in their training response to
IMT in terms of autonomic regulation. IMT may provide an effective intervention to
increase HRV.
Limitations of the Study
1. External validity may be affected by the population studied, as the results can only be
applied to populations with similar characteristics.
2. The resistance applied to the inspiratory muscles when using the IMT apparatus cannot be
adjusted to any exact value. Resistance on the IMT device can be adjusted; however there is
no way of determining the precise load on the muscles.
3. Subject adherence is important to study. It was emphasized that subjects should attend all
training sessions and subjects were dropped if they missed more than three sessions.
4. Individual subject’s respiration pattern and rate were not controlled during training.
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5. The study subjects may have been involved in regular exercise or physical activity. To
control for exercise effect, subjects were asked to keep same exercise routine without any
major changes during the study duration.
6. Environmental factors are known to affect HRV. To minimize potential influence of such
factors, the laboratory was kept at consistent room temperature and external noise was
limited.
7. Any stress or emotional disturbance due to life events occurred during the time of study
was not controllable. To minimize the effect of emotions and stress on HRV measures, a
simple visual analog scale was used to ensure no change in stress level and emotional
disturbance during ECG recording.
8. Instrumentation may have provided a source of error. A standardized protocol of
measurement was followed for each subject. All measurements were completed by the same
investigator.
Definition of Terms
Autonomic nervous system (ANS): centers, nuclei, tracts, ganglia, and nerves involved in
the regulation of smooth muscle, cardiac muscle, and glandular secretions at the
subconscious level (Martini & Nath, 2009).
Baroreflex: a reflexive change in cardiovascular activity that responds to changes in blood
pressure by adjusting cardiac output and peripheral resistance (Martini & Nath, 2009).
Electrocardiogram (ECG): an ECG is the recording of the electrical activity generated by the
cells of the heart that reaches the body surface (Wagner & Marriott, 2007).
Forced expiratory volume in one second (FEV1): the volume of air exhaled during the first
second of forced vital capacity expressed in liters (American Thoracic Society, 1994).
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Heart rate (HR): a measure of cardiac activity usually expressed as the number of heart
contractions per minute (Pagani et al., 1986).
Heart rate variability (HRV): oscillation in the interval between consecutive heart beats as
well as oscillation between consecutive instantaneous heart rates (Malik et al., 1996).
High frequency power (HF): frequency domain measure of HRV which refers to power in
the high frequency range of 0.15- 0.4 Hz (Malik et al., 1996).
HFnu: HF power in normalized units which represent the relative values of HF component
in proportion to the total power minus very low frequency (VLF) component (Malik et al.,
1996).
Inspiratory muscle training (IMT): pressure threshold loading that requires user to overcome
negative pressure, resulting in improved strength of inspiratory muscles (Caine, Waller, &
Wilcox, 2003).
Low frequency power (LF): frequency domain measure of HRV which refers to power in the
low frequency range of 0.04- 0.15 Hz (Malik et al., 1996)
LFnu: LF power in normalized units which represent the relative values of LF component in
proportion to the total power minus VLF component (Malik et al., 1996)
Maximal inspiratory pressure (MIP): Maximal inspiratory pressure is commonly used to
measure inspiratory muscle strength. It reflects the force-generating ability of the combined
inspiratory muscles during a brief quasi-static or isometric-like contraction (Volianitis,
McConnell, & Jones, 2000). Also abbreviated as PImax, it is defined as the largest negative
pressure averaged over 1 second during maximal inspiratory effort from residual volume
(Larson et al., 1993). The residual volume is the amount of air left in lugs after maximal
exhalation. Thus, the maximal inspiratory effort should be preceded by maximal exhalation.
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Maximal voluntary ventilation (MVV): the largest volume that can be breathed into and out
of the lungs with voluntary effort during a 10- to 15-s interval (Heliopoulos et al., 2003). To
measure the MVV, the subject is required to breathe as deeply and rapidly as possible. The
test is conducted for a specific interval, usually 10, 12, or 15 seconds and extrapolated to one
minute (Heliopoulos et al., 2003).
Normal to Normal interval (N-N interval): intervals between adjacent normal QRS
complexes resulting from sinus node depolarization (Malik et al., 1996). It is commonly
used in the analysis of heart rate variability. Abnormal QRS complexes are indicated by
morphological abnormalities in QRS complex on an ECG and are not often included in HRV
analysis.
Parasympathetic nervous system (PNS): division of autonomic nervous system generally
responsible for activities that conserve energy and lower metabolic rate. Parasympathetic
stimulation slows down heart rate and slightly decreases heart muscle contractility (Martini
& Nath, 2009).
R-R interval: the period between successive QRS complexes on an electrocardiogram.
Respiratory sinus arrhythmia: heart rate variability in synchrony with respiration, which is
characterized by decrease in R-R interval during inspiration and increase during expiration
(Yasuma & Hayano, 2004).
Sympathetic nervous system (SNS): division of autonomic nervous system primarily
concerned with the elevation of metabolic rate. Sympathetic stimulation increases heart rate
and contractility (Martini & Nath, 2009).
Sympathovagal balance: the balancing interaction between sympathetic and parasympathetic
branches of the ANS.
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Total power (TP): a marker of global HRV defined as variance of N-N intervals over the
temporal segment in the frequency range of approximately < 0.4 Hz (Malik et al., 1996)
Vagus nerve: nerve of the parasympathetic nervous system whose motor components affect
the heart and control smooth muscles and glands within areas monitored by its sensory
nerves (Martini & Nath, 2009).
Very low frequency power (VLF): frequency domain measure of HRV which refers to
power in the very low frequency range < 0.04 Hz (Malik et al., 1996)
Vital Capacity (VC): the maximum volume of air exhaled with a maximal forced effort from
a position of maximal inspiration expressed in liters (American Thoracic Society, 1994).
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Chapter II
Review of literature
Introduction
Heart rate variability (HRV) is a popular noninvasive tool to estimate cardiac
autonomic modulation because it is easily measured without interfering with neural functions
of the control mechanisms. Analysis of these fluctuations has been useful in providing
information regarding the physiology of the active autonomic control branches (Akselrod et
al., 1981; Pomeranz et al., 1985). The purpose of this chapter is to review literature pertinent
to physiology behind HRV, various methods of measuring HRV and physiological influences
on HRV. The first section describes the physiological mechanisms involved in heart rate
variability. In second section, various methods to measure HRV are explained with more
emphasis on frequency domain method. Various frequency domain variables are described
with their physiological correlates. Many clinical conditions are associated with
derangement of HRV profile indicating its importance in pathogenesis. The third section
provides a brief about HRV derangement in various clinical conditions. HRV is influenced
by several physiological and maturational factors.

The fourth section restricts the

discussion to the effects of aging and exercise on HRV. The modulatory effect of respiration
is described separately in the fifth section. Inspiratory muscle training (IMT) is a promising
way to improve breathing energetics at preventive as well as intervention level. The sixth
section reviews the literature pertinent to IMT and describes a few studies that have
evaluated the possible effect of IMT on autonomic regulation.
Physiology of Heart Rate Variability
The cardiovascular system is constantly challenged by a wide variety of stimuli. In
order to respond to these challenges and achieve dynamic stability, the cardiovascular system
8

is tightly regulated by the autonomic nervous system (ANS). The ANS is comprised of
control centers in the brain stem, spinal cord, hypothalamus, portions of the cerebral cortex,
and by various reflex mechanisms that direct afferent signals to these control centers.
Efferent signals are transmitted throughout the body via either sympathetic or
parasympathetic pathways (Lee, Wood & Welsch, 2003). The ANS reacts rapidly to a wide
range of external and internal stimuli and maintain dynamic stability through control of heart
rate (HR), blood pressure and several other factors. Heart rate, in particular, reacts in a
complex manner to these stimuli. It exhibits autonomically mediated self organization
through frequent small adjustments, expressed as heart rate variability. These fluctuations
are observed even at rest. The exact mechanism behind HRV is not established. It is
believed to be resulting from the interplay among several factors including respiratory
movements, intrathoracic pressure changes, peripheral vascular resistance and reninangiotensin system (Akselrod et al., 1981; Elghozi, Laude, & Girard, 1991). However, the
autonomic nervous system and its component branches mediate the effect of these factors
over heart rate.
The sinus node is densely innervated by both sympathetic and parasympathetic
divisions. They modulate the intrinsic rate of pacemaker cells of the sinus node which is
reflected in the heart rate (Pumprla, Howorka, Groves, Chester, & Nolan, 2002). The ANS
has both cardiovascular stimulatory and inhibitory control centers in the higher brain centers.
The cardioinhibitory center is found in nucleus ambigus and dorsal nucleus of the vagus
nerve (Lee et al., 2003). The vagal efferents from these sites that constitute parasympathetic
supply to heart, act to decrease both heart rate and contractility. Conversely, a
cardiostimulatory center believed to be located in the lateral medulla exerts its effect through
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the sympathetic pathways (Lee et al., 2003). Thus, sympathetic activation increases heart
rate and conduction velocity through cardiac conduction system together with an increase in
contractility (Pumprla et al., 2002). The parasympathetic influence on HR is mediated by the
vagus nerve via synaptic release of acetylcholine (ACh) which is rapidly hydrolyzed by
acetylcholinesterase in the sinus node. Thus, the vagal effect is brief owing to the short latent
period of ACh (Malik et al., 1996; Pumprla et al., 2002). The sympathetic activity is
mediated by synaptic release of epinephrine and norepinephrine, which are reabsorbed and
metabolized relatively slowly (Pumprla et al., 2002). These differences result in both of
these autonomic branches operating at different frequencies and thresholds, as reflected in
HR variations.
Modulation of the ANS is largely attributed to the presence of various autonomic
reflexes. There are three major cardiovascular reflexes: the baroreflex, chemoreflex and
cardiac sympathetic afferent reflex (CSAR) (Du & Chen, 2007). The stretch-sensitive
baroreceptors are located in the aortic arch and carotid sinus. The baroreflex is
sympathoinhibitory and thus a depressed arterial baroreflex will result in increased
sympathetic activity. It is a primary peripheral regulator of sympathetic outflow (Du &
Chen, 2007). The chemoreflex, composed of chemoreceptors and located in the internal
carotid and aortic bodies as well as brain stem, is sympathoexcitatory in nature (Du & Chen,
2007). Thus, chemoreflex activation results in increased sympathetic activity. The third
reflex, CSAR is also sympathoexcitatory, and consists of sympathetic sensory nerve endings
in the cardiac chambers and thoracic aorta. It is sensitive to both chemical and mechanical
stimulation. Thus, cardioregulation is likely to result from a complex interaction of central
integration and peripheral inhibitory and excitatory ANS reflexes (Du & Chen, 2007). HRV
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mirrors the dynamic response of these reflexes and cardiovascular control centers in order to
maintain homeostasis.
Measurement of Heart Rate Variability
Heart rate variability (HRV) is also described by several other terms such as cycle
length variability, heart period variability, R-R variability and R-R interval tachogram. HRV
remains the most commonly used term even though HRV variables represent variations in
intervals between the consecutive heart beats (R-R interval) rather than variation in HR
(Malik et al., 1996). HRV is measured from electrocardiogram (ECG) recordings in two
common settings. First, HRV is assessed from short-term (2 to 5 min) ECG recordings under
controlled laboratory conditions. Secondly, HRV is determined from long term (24 hr) ECG
recordings while subjects perform their usual tasks (Kleiger, Stein, & Bigger, 2005). In
either condition, the data obtained are used to quantify HRV variables by analyzing it using
add-on software or dedicated HRV analyzers. The Task Force of European Society of
Cardiology and the North American Society of Pacing and Electrophysiology describes
standards of methods to measure HRV. These methods are categorized into non-linear and
linear methods.
The non-linear method attempts to quantify the structure or complexity of the R-R
interval time series, while the linear methods quantify R-R interval on various time and
frequency scales (Kleiger et al., 2005). The methods commonly used to measure non-linear
properties of HRV include detrended fluctuation analysis, correlation function, Hurst
exponent, fractal dimension and Lyapunov exponent (Vanderlei, Pastre, Hoshi, Carvalho, &
Godoy, 2009). The linear methods include analysis in time and frequency domains, and the
time domain methods are the simplest to perform (Malik et al., 1996; Stein & Kleiger, 1999).
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In these methods, the intervals between adjacent normal complexes, called normal to normal
interval (N-N interval), are measured over a period of time and various indices are derived by
statistical or geometrical methods (Malik et al., 1996). HRV analysis in the frequency
domain is mathematically more complex, but it is perhaps the most widely used technique.
In the frequency domain method, power spectral density (PSD) analysis yields
information about the distribution of amount of variance (power) of periodic oscillations of
heart rate as a function of frequency (Malik et al., 1996). PSD can be calculated by using
non-parametric or parametric methods. The non-parametric method typically uses a simple
algorithm, mostly Fast Fourier Transform-FFT, and is preferred over autoregression
techniques used in the parametric method. PSD analysis of short term recording decomposes
HRV into fundamental spectral components that are defined as follows: 1) Total power (TP),
the variance of N-N intervals over the temporal segment in the frequency range of
approximately < 0.4 Hz; 2) High frequency component (HF), power in high frequency range
of 0.15- 0.4 Hz; 3) Low frequency component (LF), power in low frequency range of 0.040.15 Hz; 4) Very low frequency component (VLF), power in very low frequency range <
0.04 Hz. Spectral analysis of long term analysis often includes an additional ultra low
frequency component (ULF).
These spectral components are correlated to branches of ANS and their regulatory
mechanism in terms of physiological origin and frequency range. The high frequency
component (HF) is parasympathetically mediated (Akselrod et al., 1981; Pomeranz et al.,
1985; Raeder et al., 1987). The studies that investigated the effect of muscarinic
parasympathetic blockade with glycopyrorolate or atropine have demonstrated a decrease in
HF power with parasympathetic withdrawal (Akselrod et al., 1981; Pomeranz et al., 1985;
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Saul, 1990). Similarly, in instances of vagotomy, HF power was completely abolished
(Raeder et al., 1987). High frequency power reflects respiratory modulation of R-R intervals
which occurs around 0.25 Hz (respiratory sinus arrhythmia) (Yasuma & Hayano, 2004).
Respiration acts as a primary modulator of vagal activity and thus plays a vital role in
modulating HF power. The LF component is influenced by both sympathetic and
parasympathetic nervous activity (Akselrod et al., 1981; Pomeranz et al., 1985; Raeder et al.,
1987; Saul, 1990). When sympathetic activity was blocked and arterial pressure was
increased, the parasympathetic activity was reflexively increased, and increase in LF power
was observed (Akselrod et al., 1981). On the other hand, under the condition of
parasympathetic blockage with an accompanying decrease in arterial pressure, sympathetic
activity was reflexively increased, and LF power was increased (Akselrod et al., 1981).
Thus, increasing the activity of either sympathetic or parasympathetic nervous system
augmented the LF power. HRV in the low frequency band is primarily modulated by
baroreflex response to blood pressure fluctuations mediated by a combination of sympathetic
and parasympathetic drives (Bernardi et al., 1994; Pomeranz et al., 1985; Stein & Kleiger,
1999). The VLF component is far less defined and its physiological correlates are not well
established. Changes in autonomic activity associated with the renin-angiotensinaldosterone, thermoregulation and peripheral vasomotor systems are thought to be related to
VLF (Taylor, Carr, Myers, & Eckberg, 1998). It is proposed that they depend primarily on
the presence of parasympathetic outflow and diminish with parasympathetic block (Taylor et
al., 1998).
Measurement of VLF, LF and HF power components is usually made in absolute
values of power (ms2). Because VLF cannot be measured accurately from short term

13

recordings, LF and HF are also reported in normalized values which represent the relative
values of each power component in proportion to the total power minus VLF component.
Normalization tends to control the effect of changes in total power on the values of HF and
LF (Malik et al., 1996; Sandercock & Brodie, 2006). Another expression in the form of a
ratio (LF/HF) provides efficient use of power spectral analysis of HRV to assess a shift in
sympathovagal balance (Montano et al., 1994; Pagani et al., 1986). Increase in LF/HF
indicates the progression of sympathetic excitation (increasing LF) over concomitant vagal
withdrawal (increasing both HF & LF), and consequently a shift to sympathetic excitation
(Montano et al., 1994; Pagani et al., 1986). Malliani, Pagani and Lombardi (1994) supported
evaluation of LF and HF component in normalized units and evaluation of sympathovagal
balance by LF/HF ratio in numerous physiologic and physiopathologic conditions.
Heart Rate Variability in Clinical Conditions
High heart rate variability is a sign of good adaptability which implies a healthy
individual with well functioning autonomic control mechanisms. A reduced HRV (low TP,
low HF) has been identified as a strong predictor of risk related to adverse events in healthy
individuals and patients with a large number of diseases.
Deranged HRV variables have been associated with mortality related to several
cardiovascular pathologies. In myocardial infarction and diabetic autonomic neuropathy, low
or reduced values of HRV variables are strongly and independently associated with mortality
and adverse prognosis (Kleiger, Miller, Bigger, & Moss, 1987; La Rovere, Bigger, Marcus,
Mortara, & Schwartz, 1998; Steeds et al., 2004). Similarly, in patients of chronic heart
failure (CHF), reduction in HRV variables is an independent predictor of high risk of death
(Nolan et al., 1998; Ponikowski et al., 1997). It has been observed that HRV analysis has
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better prognostic value than other conventional clinical measurements and risk factors
evaluation (Nolan et al., 1998; Tsuji, et al., 1996; Tsuji et al., 1994). Low heart rate
variability has been inferred as a risk factor for life threatening ventricular and sudden death
in clinical conditions of chronic heart failure, cardiac arrest and diabetes (Dougherty & Burr,
1992; Galinier et al., 2000; Kataoka, Ito, Sasaki, Yamane, & Kohno, 2004; La Rovere et al.,
2001). Several other significant clinical conditions that are associated with low HRV include
hypertension, metabolic syndrome and chronic obstructive pulmonary disorder (COPD)
(Liao et al., 1998; Pagani et al., 1996; Singh et al., 1998). This reflects the vital role that
ANS plays in maintaining health. Any intervention to improve HRV (increase TP, HF, lower
LF/HF ratio) thus has applications in several clinical conditions as well as health promotion.
Physiological Influences on HRV
As age advances, the cardiovascular and nervous systems go through changes. These
physiological changes associated with maturation of both the systems affect heart rate
variability. The cardiovascular system is readily influenced by transient external stimuli that
can change the sympathetic-parasympathetic interaction. Mechanical, gravitational,
emotional, acoustic or thermal stimulation are only a few amongst many possible stimuli.
Exercise is one such potent stimulus that promotes long standing changes in HRV. This
section reviews the influence of aging and the effect of both aerobic and resistance exercise
training on heart rate variability.
Age influences. HRV changes with advancing age. HRV is high in gestational and
postnatal life. Infants have a high sympathetic activity as indicated by high LF power. It
decreases quickly between ages of five and 10 years as the parasympathetic system matures
(Finley, Nugent, & Hellenbrand, 1987). In adolescence, the advanced cardiovascular

15

parasympathetic system predominates against a strong sympathetic system (Korkushko,
Shatilo, Plachinda, & Shatilo, 1991). With advancing age, heart rate variability decreases
gradually over years.
Schwartz, Gibb, & Tran (1991) studied HRV in 56 healthy subjects from age 20 to
81years and observed total power, high frequency and low frequency components of HRV to
decrease with aging. Shannon, Carley, & Benson (1987) investigated HRV in 33 healthy
male subjects (aged 9 to 62 years) and observed a decline in total power and its LF and HF
components with aging. Several other studies have observed similar decline in time and
frequency domain HRV variables (Antelmi et al., 2004; Beckers, Verheyden, & Aubert,
2006; Melo et al., 2005; O'Brien, O'hare, & Corrall, 1986; Yeragani, Sobolewski, Kay,
Jampala, & Igel, 1997; Zhang, 2007).
Yeragani et al. (1997) studied HRV in 33 healthy subjects aged from six to 61 years.
HRV was obtained from a 24-hour Holter ECG and analysed by power spectral method. The
adult group (35.4 + 10.4 years) demonstared significantly lower total power, HF, LF and
higher LF/HF ratio (TP: 4.5 + 0.4 bpm2, LF: 1.8 + 0.5 bpm2, HF: 0.5 + 0.8 bpm2, LF/HF: 3.8
+ 1.7) in comparison with children group (11.1 + 2.1 years) (TP: 4.8 + 0.3 bpm2, LF: 2.0 +
0.4 bpm2, HF: 1.3 + 0.5 bpm2, LF/HF: 2.3 + 0.8). It was suggested that the increase in
LF/HF probably reflects a steeper decline in HF power with age.
Antelmi and associates (2004) studied time and frequency domain HRV variables in
653 apparently healthy subjects. The HRV was analyzed in both time and frequency
domains and compared within subjects categorized in six age strata (< 19, 20-29, 30-39, 4049, 50-59, > 60 years). Comapision between age groups showed that all time domain
variables (SDNN, SDANN, rMSSD, pNN50) and frequency domain variables (LF, HF, VLF)
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decreased with age. HF, rMSSD, and pNN50 which are indexes of parasymapthetic
modulation decreased significantly until the fourth decade and decreased nonsignificantly in
the older age groups. The LF/HF increased with age, with significant increase from the
second to the fifth decade.
These observations are attributable to age related marked morphological and
functional changes in cholinergic and adrenergic innervations of the heart. It is well known
that baroreflex activity decreases with aging (Ebert, Morgan, Barney, Denahan, & Smith,
1992; Monahan, 2007). There is an impairment of the parasympathetic component while the
sympathetic component can be well maintained (Ebert et al., 1992; Ferrari, Radaelli, &
Centola, 2003; Monahan, 2007). With advancing age neurotransmitters are not as effective
at the level of target organs (Lakatta, 1993). The endogenous effect of acetylcholine (Ach) is
diminished with age. In addition, the number of cholinergic receptors (M2 receptors) and
their response to acetylcholine decreases with age leading to decreases in cardiac
parasympathetic activity (Brodde et al., 1998; Brodde & Leineweber, 2004; Poller, Nedelka,
Radke, Pönicke, & Brodde, 1997). In adults, along with impairment of cholinergic system
with aging, low HF power is attributable to attenuation of respiratory sinus arrhythmia or
respiratory modulation of R-R interval (Pagani et al., 1996; Shannon et al., 1987). Similar
age related reductions are also observed in adrenergic modulation with decrease in βadrenergic receptor density and responsiveness (Brodde & Leineweber, 2004; Lakatta, 1993).
Despite age related impairment in sympathetic tone, there appears a relative prevalence of
sympathetic influences upon heart rate control against a background of more markedly
decreased parasympathetic influences (Korkushko et al., 1991).
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Short term stability of heart rate variability. It is clear that heart rate variability
declines with aging. These changes occur slowly over the years. Heart rate variability is
demonstrated to be stable over relatively short periods.
Kleiger et al. (1991) assessed the stability of HR variability over time in fourteen
normal subjects aged 20 to 55 years. HRV was analyzed from 24-hour ambulatory
electrocardiograms performed three and 65 days apart. The HRV variables analyzed
included both the time domain (SDNN, rMSSD, rNN50) and the frequency domain (LF, HF,
TP) measures. The mean and standard deviations of these measures were virtually identical
within the time range studied.
Another study by Tarkiainen et al. (2005) assessed the stability of short term HRV
over a three to four month period in 89 subjects with stable coronary artery disease (age 4083 years). The HRV assessments were performed from a 40-minute ECG recordings
consisting of five minute periods of rest, paced breathing and standing, a six minute
submaximal exercise test and a 10-minute period of recovery. The coefficient of variation
(CV) varied between 5.1–16.7% for the 40-minute and 6.0–37.1% for the 5-minute time
domain variables and 4.4–11.0 % for the 40-minute and 7.2–16.5 % for the 5-minute
frequency domain measurements. The mean of the RR intervals and the total power showed
the highest stability over time.
Heart rate variability does not vary much and remains stable unless there are present
any physiological influences like exercise training, breathing exercises or similar
interventions. The following sections elaborate on the effects of such physiological
influences.
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Aerobic exercise training. There are many studies supporting that HRV is affected
by exercise training and physical activity status. Cross-sectional differences between
trained/athletes and recreationally active/sedentary individuals support the notion of
increased parasympathetic and/or decreased sympathetic drive with physical activity or
training status. The cross sectional study by Mølgaard, Sørensen, & Bjerregaard (1991)
evaluated 24-hour holter monitoring in 140 apparently healthy subjects aged 40 to 77 years.
The subjects were classified as active, intermediate and passive, according to their
participation in leisure time physical activity. It was observed that high physical activity (in
active subjects) was independently associated with significantly higher values of mean R-R
interval, standard deviation of R-R intervals (SD) and percentage of successive R-R interval
differences.
When assessed during the resting condition, active young and older men had lower
heart rates and higher values of HRV variables in both time and frequency domains when
compared to sedentary men (Melo et al., 2005). The young active group was significantly
different from young sedentary group in values of R-R interval (active 1034 + 100.3 ms,
sedentary 874 + 123.8 ms), RMSSD index (active 63 + 19.9, sedentary 34 + 14.6), LFnu
(active 27 + 12.2 NU, sedentary 35 + 16.9 NU), HFnu (active 72 + 12.2 NU, sedentary 65 +
16.9 NU), LF/HF (active 0.41 + 0.3, sedentary 0.65 + 0.6). Similarly, smaller sympathetic
driven variables and greater parasympathetic driven variables were observed in the old
active group when compared to the old sedentary group, reported as RR interval (active
1109 + 186.3 ms, sedentary 893 + 93.8 ms), RMSSD index (active 48 + 22.4, sedentary 27 +
9.2), LFnu (active 43 + 9.9 NU, sedentary 46 + 7.4 NU), HFnu (active 56 + 9.9 NU,
sedentary 54 + 7.4 NU), LF/HF (active 0.81 + 0.3, sedentary 0.87 + 0.2). In both active
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young and older men, LF/HF was lower than that in sedentary adults indicating higher
parasympathetic activity associated with physical activity status. It can also be observed that
the active and sedentary older men demonstrated lower HF power and higher LF power, and
thus greater LF/HF compared to younger men.
Rennie et al. (2003) in their cross-sectional study investigated HRV in 3328
apparently healthy civil servants (age 45- 68 years). Leisure time physical activity was
categorized as moderate (>3 to <5 metabolic equivalent hours per week) and vigorous (>5
metabolic equivalent hours per week). It was observed that lower heart rates and higher HF
power were associated with moderate activity (p < 0.05) and vigorous activity (p < 0.01).
When parasympathetic activity was assessed by 24 hour recordings in endurance
trained and untrained young men, HF power was significantly greater in endurance trained
men (during the day: 852 versus 177 ms2, p < 0.005; during the night: 1,874 versus 427 ms2,
p < 0.005 and over the entire 24 hour 1,165 versus 276 ms2, p < 0.001) (Goldsmith, Bigger,
Steinman, & Fleiss, 1992). This indicates that parasympathetic activity is substantially
greater in trained men.
Similarly, the power spectrum of HRV measured in physiological conditions of 45
minute resting, 10 min standing, and 15 min steady state exercise at 50% maximum workload
was assessed in endurance athletes and sedentary controls (Dixon, Kamath, McCartney, &
Fallen, 1992). Though there was no significant difference in response to standing and
exercise induced changes in HRV, in the resting condition the LF peak power was
significantly reduced (p < 0.05) in athletes (54 +9.9 beats.min-1Hz-1) when compared to
controls (69.6 + 19.5 beats min-1 Hz-1),. The endurance athletes had higher HF peak (62.2 +
10.7 beats min-1 Hz-1) than controls (43.7 + 22.4 beats min-1 Hz-1), while the area contained
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within HF band was greater (p < 0.01) in athletes (54 + 4.4 %) versus controls (43.3 +
11.4%). This association of higher HRV (HF) with training status suggests that HRV may be
improved with training.
The observations from the studies that have investigated the effects of exercise
training on HRV variables support this notion. Results from these studies imply the
modification of HRV with training by means of increase in global HRV and variables related
to parasympathetic component. However, contradictions exist about the adequate volume of
training necessary to achieve significant beneficial results. Exercise training of variable
duration and intensity influences heart rate variability.
Sandercock, Grocott-Mason, and Brodie (2007) examined changes in HRV measures
after eight weeks of cardiac rehabilitation in 38 cardiac patients. The training included
aerobic training at an intensity of 70 % of maximum heart rate. HRV was analyzed from five
minute ECG before and after training. The results demonstrated significant increases in
SDNN (pre 29 + 15 ms, post 35 + 17 ms, p < 0.015) and RMSSD (pre 26 + 14, post 33 + 16,
p < 0.095). The HF and LF measured in log units, increased significantly (HF: pre 3.8 + 1.0,
post 4.3 + 0.3, p < 0.024; LF: pre 2.4 + 1.2, post 3.0 + 2.4, p < 0.014). These results suggest
increased parasympathetic modulation of heart rate with aerobic training.
Tulppo et al. (2003) evaluated the effect of eight weeks of moderate (30 min exercise
sessions) and high (60-min exercise sessions) volume at an intensity of 70-80% of maximum
HR. The subject population consisted of twenty healthy sedentary males in each of the
training groups and fifteen subjects in the control (no training) group. The normalized HF
increased (p < 0.01) and LF/HF decreased (p < 0.05) in both training groups, while the HRV
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in control group remained unchanged. The high volume training had no significantly greater
result compared to moderate volume aerobic training.
Similarly, Carter, Banister, & Blaber (2003) investigated the effect of a 12-week
training program in young (age 19-21 years) and middle aged runners (age 40-45 years). The
training included 45- 60 min of running at an intensity of 70 - 90% of subjects’s maximum
heart rate. The young group demonstrated an increase in TP (pre 1161.82 + 59.85 ms2, post
2010.82 + 59.85 ms2, p < 0.001) and HF (pre 362.26 + 82.61 ms2, post 926.68 + 82.61 ms2, p
< 0.01) The middle aged group also increased TP (pre 528.94 + 59.85 ms2, post 727.24 +
59.85 ms2, p < 0.05) and HF (pre 49.18 +82.61 ms2, post 168.19 + 82.61 ms2, p < 0.01). The
aerobic exercise influneced HRV in both age groups. Younger individuals experienced
higher total power and high-frequency power prior to and following training program;
however, older individuals experienced a greater overall training response (Carter et al.,
2003).
Melanson and Freedson (2001) investigated the effect of a 16-week aerobic training
in previously sedentary adult males and found significant increases in pNN50, rSMMD, and
HF. The most important finding from this study was that significant changes in HRV were
apparent after only 12 weeks of training at 70-80 % of heart rate reserve. Another study
(Killavuori, Toivonen, Naveri, & Leinonen, 1995) reported a significant increase in HF
power by 22-25% after three months of training at a workload corresponding to 50-60% of
peak oxygen consumption.
A cross-sectional study (Buchheit, Simon, Piquard, Ehrhart, & Brandenberger, 2004)
analyzed HRV in young subjects divided in three groups according to their weekly training
load (sedentary subjects (< 2 hr/wk), moderately trained (4-6 hr/wk) and highly trained (> 18
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h/wk)). Except for the lower heart rate and higher SDNN, RMSSD and HF during slow wave
sleep, highly trained subjects did not show any significantly greater differences during
waking periods in the aforementioned variables as compared to the moderately trained
subjects.
Thus, it is common observation that exercise training using moderate to high intensity
lasting about eight to twelve weeks elicited significant changes in HRV. Increase in HRV
following aerobic training has been documented over a range of age groups. In the study by
Levy et al. (1998), standard deviation of R-R interval at rest was increased by 68% in older
(age 60 to 82 years) men and 17% in young (age 24 to 32 year) in response to six months of
training. It is important to note that the older individuals experience a greater overall training
response (Carter et al., 2003). The observation is applicable to both genders.
Resistance exercise training. The effect of resistance training on HRV has been
explored in the literature to a much lesser extent than aerobic training. The results are
inconsistent among studies and many studies were unable to show any effect of resistance
training on HRV. Multi week resistance training studies have examined the effects of
programs ranging from four weeks to six months duration with the resistance levels varying
from 60 - 85% of one repetition maximum. The training mode most commonly included
isotonic weight training, weight machines, isometric dynamometer and leg ergometry
(Collier et al., 2009; Figueroa, Kingsley, McMillan, & Panton, 2008; Selig et al., 2004).
Collier et al. (2009) evaluated the effect of a four week resistance training program in
individuals with mild hypertension. The training program included three sessions per week
with three sets of ten repetitions of various resistance exercises. The log-transformed heart
rate variability measure did not demonstrate an significant improvement with resistance
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training (TP: pre 7.45 + 0.32 ms2, post 7.46 + 0.34 ms2; HF: pre 5.98 + 0.28 ms2, post 5.76 +
0.42 ms2; LF: pre 6.1 + 0.35 ms2, post 6.0 + 0.39 ms2). Another study by Sloan et al. (2009)
examined the effect of 12-week resistance training using similar protocol in healthy
sedentary young adults and reported no improvement in any of HRV variables assessed.
Conversely, prolonged resistance training has resulted in favorable changes in HRV
(Figueroa et al., 2008; Selig et al., 2004). Figueroa and associates (2008) investigated the
effect of 16 weeks of resistance training in women with fibromyalgia. After resistance
training, there were significant increases in total power, square root of standard deviation of
R-R interval and high frequency power. Similar increases in HF power were observed in
patients with chronic heart failure after 3 months of resistance training (Selig et al., 2004).
Though the results have been inconsistent, it is important to note that HRV is affected
by training, aerobic or resistance training. The studies reviewed further indicated that HRV
is influenced by not only intrinsic factors such as age or disease status, but also external
factors like training influence the parasympathetic and sympathetic modulation of heart rate.
The other observation from these studies is that HRV does not change significantly over
short duration, unless there is any exercise intervention (Buchheit et al., 2004; Melanson &
Freedson, 2001; Sandercock, Grocott-Mason, & Brodie, 2007; Tulppo et al., 2003).
Modulatory Effect of Respiration on HRV
Respiration is the most consistent and important external modulator of heart rate
variability. The circulatory and respiratory systems are interconnected anatomically and
physiologically. Respiratory sinus arrhythmia (RSA) is one of the physiological interactions
between respiration and cardiovascular system. This section explores on how respiration
contributes to genesis of heart rate variability, majorly RSA. The heart rate changes with
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changes in respiration rate and pattern. This section also elaborates on how respiration rate
and pattern affect heart rate variability.
Genesis of respiratory sinus arrhythmia. Respiratory sinus arrhythmia (RSA) is
heart rate variability in synchrony with respiration, characterized by the R-R interval on an
ECG shortening during inspiration and increasing during expiration (Yasuma & Hayano,
2004). RSA primarily contributes to the high frequency component of HRV that occurs at
respiratory frequency > 0.25 Hz (Bernardi et al., 1989; Kleiger et al., 2005; Pumprla et al.,
2002; Saul, 1990; Stein & Kleiger, 1999). The origin of RSA is debatable. Among several
factors suggested to be involved in genesis of RSA are the baroreflex mediated responses to
arterial pressure fluctuations, modulation of vagal-cardiac motonurone firing by phasic
afferent pulmonary and thoracic stretch receptor inputs, and phasic mechanical stretch of
sinus node (Bernardi et al., 2001; Koh, Brown, Beightol, & Eckberg, 1998).
The most prominent mechanism behind RSA is the arterial baroreceptor response
(Bernardi et al., 2001). The baroreflex is stimulated by inspiratory increase in venous return
with subsequent changes in arterial pressure. Thus, the influence of breathing on autonomic
activity may be secondary to respiratory related fluctuations on arterial baroreceptor activity
(Davidson, Goldner, & McCloskey, 1976; Davis, McCloskey, & Potter, 1977; Elghozi et al.,
1991). It is also demonstrated in the study by Piepoli et al. (1997) where RSA was restored
during apnea by stimulating carotid baroreceptors by cycled neck suction at the frequency of
the previous respiration. Conversely, RSA was considerably suppressed by neck suction
appropriately phased so as to smooth out respiration related blood pressure changes.
However, the strong correlation between systolic pressure and R–R intervals at respiratory
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frequencies reflects the influence of respiration on these two measures, rather than arterial
baroreflex physiology (Badra et al., 2001; Eckberg, 2003).
Koh et al. (1998) demonstrated the effect of mechanical lung inflation on R-R interval
and arterial pressure fluctuations in nine healthy young adults undergoing elective orthopedic
surgery. Following sedation and induced muscle paralysis, the subjects were ventilated with
intermittent positive pressure ventilation or high frequency jet ventilation. The R-R interval
spectral power (index of RSA) declined dramatically with sedation and muscle paralysis, but
was greater during mechanical ventilation. It was suggested that phasic inputs from
pulmonary and thoracic stretch receptors make small but statistically significant contribution
to respiratory sinus arrhythmia. Bernardi et al. (1989) observed a reduced RSA that persisted
after transplantation despite the fact that recently transplanted heart is denervated; a direct
influence of myocardial wall stretch on sinus node independent of autonomic influence was
suggested for this observation. On the similar background, Raeder et al. (1987) observed a
minimal degree of fluctuations in heart rate variability in an anesthetized dog after
denervation (bilateral cervical vagotomy). These fluctuations were abolished by equalization
of intrathoracic pressure indicating that non-neural mechanisms contributed to these
fluctuations (later identified as RSA). Thus, it may imply from above that respiration can
exert its modulatory effect on heart rate variability independent of autonomic nervous
system.
Effect of respiration rate and pattern on HRV. There is a clear interaction
between the frequency of breathing and heart rate variability. This can be seen in healthy
subjects or in subjects with autonomic dysfunction of various origins. Radelli et al. (2004)
observed that slow controlled breathing at the rate of six breaths/min in healthy young males
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was associated with a significant reduction in blood pressure and a significant increase in RR interval. When evaluated in patients with chronic heart failure, slow breathing resulted in
significant increases in baroreflex sensitivity (Bernardi et al., 2002).
Hirsch and Bishop (1981) investigated the influence of breathing frequency and tidal
volume on RSA in healthy subjects (age 22-78 years). They found that RSA increased with a
respiratory rate of six breaths/min and decreased as breathing rate was increased. It may
imply that breathing at a lower frequency appears to be more effective on autonomic
modulation of heart rate control than breathing at higher frequency. This study also study
observed increases in amplitude of RSA with increases in tidal volume thereby concluding
that RSA amplitude depends on both the depth and frequency of breathing.
Brown et al. (1993) investigated the influence of breathing frequency (6, 7.5, 10, 15,
17-1, 20 and 24 breaths/min) and tidal volume on R-R interval power spectra in healthy
subjects (age 23-32 years). It was observed that R-R interval power in LF and HF spectra
declined significantly with increasing breathing frequency. It appeared that breathing
frequency influences R-R interval power spectra in both low frequency and high frequency
and more likely redistributes autonomic outflow within the respiratory cycle without altering
the levels of autonomic traffic. Similar to the study by Hirsch and Bishop (1981), they
observed that breathing rate more than 10 breaths/min yielded reduced levels of R-R interval
power in an inverse relationship to breathing rate.
The respiratory modulation of cardiac autonomic control is also supported by studies
investigating the training effects of various breathing patterns in yoga. Pranayam or
pranayamic breathing involves conscious inhalation, retention and exhalation. Pal,
Velkumary & Madanmohan (2004) investigated the effect of three months of pranayama on
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heart rate. The study involved 30 male volunteers (age 17- 19 years) each in fast (fast
inspiration and expiration for a minute) and slow breathing (5-breaths/min) groups. After
three months, heart rate in response to standing and deep breathing along with valsalva ratio
were evaluated. The heart rate response was significantly lower in the slow breathing group
when compared to the control and fast breathing groups. Another study (Raghuraj,
Ramakrishnan, Nagendra, & Telles, 1998) evaluated two breathing techniques in yogaKapalabhati (rapid and forceful breathing for a minute at a rate of 120 breaths per minute)
and Nadisuddhi (very slow alternate nostril breathing for 15 minutes). Twelve male
volunteers (age 21-33 years) with an average experience of 19.7 ± 12.8 months in these two
breathing techniques participated in this cross-sectional study. HRV was assessed before and
after each practice on separate days. The results showed a significantly increased low
frequency (LF) power and LF/HF, and decreased high frequency (HF) power following
Kapalabhati. The authors attributed the observations to sympathetic excitation with rapid
breathing causing LF to increase. The decrease in HF was attributed to initial higher HF
power. There were no significant changes following Nadisuddhi. Varying breathing rate and
depth has influence on sympathetic and parasympathetic balance thereby affecting HRV.
Respiration is a powerful modulator of heart rate variability and it plays an important
role in its genesis of RSA and its distribution. Respiratory variations in frequency and depth
influences autonomic control mechanisms. It may imply that the changes in respiratory
pattern can be used to manipulate ANS control over cardiovascular system. The respiratory
patterns are easily manipulated voluntarily; training of some aspects of respiratory function
may temporarily or permanently influence cardiovascular modulation.
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Inspiratory Muscle Training
One possible method to train respiratory function is inspiratory muscle training
(IMT). IMT, as its name suggests, is training of inspiratory muscles against resistance.
Devices have been developed to improve inspiratory muscle strength. Most of the devices
use some variation of threshold pressure loading. Training at threshold pressure permits
loading at a quantifiable intensity by providing near flow-independent resistance to
inspiration (Caine & McConnell, 2000). This is typically achieved by IMT devices requiring
subjects to create a negative pressure to overcome the resistance when inhaling and working
against resistance, thereby strengthening the inspiratory muscles of the body (Gething,
Williams, & Davies, 2004). The resistance is usually set by spring-loaded mechanism.
IMT typically uses the basic principles of resistance training. Ventilatory muscles
have shown similar adaptations to training as that of other skeletal muscles by using training
principles (frequency, intensity, duration) that apply for any other striated muscle (Koessler
et al., 2001). The specific functional improvement and adaptive changes in the structure of
ventilatory muscles in response to inspiratory training are also similar to those changes seen
in limb muscles (Ramirez-Sarmiento et al., 2002). This study demonstrated that inspiratory
training for five weeks, five times a week and at an intensity of 40 to 50% of MIP in patients
with COPD, induced increases in proportion of type I fibers (approximately 38%, p < 0.05)
and in the size of type II fibers (approximately 21%, p < 0.05) of external intercostals.
It is observed that IMT results in a significant increase in contracted diaphragm
thickness and velocity of movement of diaphragm during quiet breathing (Darnley et al.,
1999; Enright, Unnithan, Heward, Withnall, & Davies, 2006). The study by Enright et al.
(2006) examined the effects of eight weeks of IMT at 80% of MIP, three times a week in
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healthy young subjects (age, 21yrs) and observed a significant increase in the contracted
diaphragm thickness (Tdi.cont) and diaphragm thickening ratio (abbreviated as TR, is ratio of
diaphragm thickness during maximal inspiratory pressure maneuver at functional residual
capacity, to mean thickness while relaxing at functional residual capacity) (Tdi.cont: pre 4.1
mm, post 4.6 mm, p < 0.05; TR: pre, 3.8, post 4.1, p < 0.05).
Despite these observations, there is yet no clear agreement that the training principles
always apply to the inspiratory muscles to exhibit similar training response as skeletal
muscles. However, inspiratory muscles improve in strength and endurance in response to
inspiratory training. The inspiratory muscle strength is often assessed directly by measuring
MIP, while endurance of inspiratory muscles is assessed by measuring sustained maximal
inspiratory pressure (SIP) or performance in various functional tests. IMT improves
inspiratory strength and endurance in healthy as well as clinical population (Inbar, Weiner,
Azgad, Rotstein, & Weinstein, 2000; Volianitis et al., 2001; Sturdy et al., 2003).
The study by Inbar et al. (2000) was a randomized controlled trial with twenty welltrained endurance athletes. The training group completed 10-week IMT training using
inspiratory muscle trainer for 30 min, six times a week, while the control group received
similar training with the same device but with no resistance. The training group started
training with at a resistnce of 30% of MIP for one week. The resistance was then incraesed
by 5% each seesion to reach 80% of their MIP, at the end of first four weeks and then
adjusted every week to 80% of the new MIP achieved. The training group demonstrated a
significant increase in inspiratory muscle strength (MIP) (pre 142.2 + 24.8 cmH2O, post
177.2 + 32.9 cmH2O, p < 0.005). The inspiratory strength remained unchanged in the control
group. The inspiratory endurance (maximal pressure that can be tolerated for 60 sec)
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increased significantly (pre 121.6 + 13.7 cmH2O, post 154.4 + 22.1 cmH2O, p < 0.005), but
not in the control group.
Gething, Passfield, & Davies (2004) compared the effects of six weeks of IMT at
maximal (100% MIP) & submaximal (80% MIP) intensities in healthy young subjects. The
training was conducted three times per week and each session consisted of ten attempts at
maximal or submaximal intemsity. The increase in MIP was significantly greater for the
maximal intesntiy group (32 + 19 cmH2O, p = 0.011) than the submaximal intensity group
(37 + 25 cmH2O, p = 0.001) relative to the control group without training.
IMT has been investigated in various clinical conditions and it has shown to improve
the inspiratory function. The study by Sturdy et al. (2003) examined the effect of eight
weeks of IMT in subjects with moderate to severe COPD. The training consisted of 25
minute sessions three times per week at an intensity of 70% of MIP. On completion of
training, muscle strength (PImax) increased by 32 + 27 % (p < 0.05) and endurance
(maximum pressure generated against a progressively increasing load [Pthmax]) increased by
56 + 33 % (p < 0.05).
Similarly, the aforementioned controlled study by Enright et al. observed an increase
in inspiratory strength by 41%, as assessed from MIP (pre 90 cmH2O, post 127 cmH2O, p <
0.01). The inspiratory muscle endurance (SIPmax) also improved by 36% in the training
group (pre 504 pressure-time units, post 688 pressure-time units, p < 0.01). The control
group who did not participate in any form of training demonstrated no change in MIP and
SIPmax. Another studies using high intensity IMT (60% and 70% of PImax) have also
demonstrated increase in inspiratory muscle strength and endurance in chronic obstructive
pulmonary disorder (Covey et al., 2001; Koessler et al., 2001; Riera et al., 2001)
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In the study by Laoutaris et al. (2004), patients with chronic heart failure received
IMT training using 15% of SIPmax (control) and 60% of SIPmax (training), three times in a
week for 10 weeks. The training group significantly increased both maximum inspiratory
pressure (83 + 5.7 versus 111 + 6.8 cmH2O, p < 0.001) and SIPmax (367360 + 41111 versus
527822 + 51358 cmH2O/sec x 10-1, p < 0.001) when compared to the control group. An
improvement in peak VO2 and six minute walking distance was also observed. This study
also observed a significant reduction in resting heart rate in the training group (80 + 3 bpm
versus 77 + 3.3 bpm, p < 0.05).
Using lower intensity for IMT is not uncommon. The randomized placebo-controlled
study by Dall’Ago et al. (2006) evaluated the effect of IMT in sixteen patients with chronic
heart failure. The 12-week IMT program included 30-min sessions using 30% of SIPmax,
seven times a week. This study found increases in PImax as well as walking distance. IMT
significantly increased inspiratory muscle strength and resulted into generalized
improvements in expiratory pulmonary function in persons with multiple sclerosis (Fry,
Pfalzer, Chokshi, Wagner, & Jackson, 2007). This study used a 10-week IMT exercise
protocol where three sets of 15 repetitions were performed daily. The initial resistance used
was 30% of maximal inspiratory pressure (MIP) and it was progressed every week 1-or 2cmH2O according to RPE and patients’ symptoms. The results also showed significant
improvement in expiratory outcomes including FEV1, forced vital capacity (FVC) and midexpiratory flow rate.
Jong et al. (2001) conducted a controlled trial to evaluate the effect of IMT in patients
with cystic fibrosis. The training group performed IMT using 40% of PImax, 20 min a day,
five days a week for six weeks. The training intensity for control group was 10% of PImax.
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After six weeks of training, mean inspiratory muscle endurance (% PImax) increased from
49% to 64% and the change in inspiratory muscle endurance in the training group was
significantly higher than in the control group.
The observations in studies evaluating IMT are primarily dependent on training
modes, intensity, duration and the initial fitness level of the study population. IMT has been
widely explored for its influence in sports and performance, as well as clinical conditions.
The majority of the studies that tested the effects of IMT have used a three to five days per
week training protocol. The duration of IMT programs vary most commonly from six weeks
to ten weeks. The intensity used for IMT varies widely between 40% -80% of the subject’s
maximal inspiratory pressure (MIP) or maximal sustained inspiratory pressure (SIPmax).
Most studies evaluating IMT in clinical conditions have used lower intensities like 30-40%,
while the protocols using high intensity in clinical population are not uncommon. The higher
intensity using 60% to 80% of MIP was widely used in sports training and performance
(Inbar, Weiner, Azgad, Rotstein, & Weinstein, 2000; Volianitis et al., 2001).
It is clear that IMT improves inspiratory muscle strength and endurance. It also
improves vital capacity and forced expiratory volume and exerts some influence on
expiratory measures (Fry et al., 2007). IMT also improves dyspnea and quality of life
(Laoutaris et al., 2004; Riera et al, 2001) and performance (Romer, McConnell, & Jones,
2002; Voliantis et al, 2001). The effect of IMT is not restricted to these parameters. A few
studies have investigated the acute and prolonged influence of IMT on parameters other than
respiration.
Inspiratory muscle training and autonomous nervous system. Chiappa et al.
(2008) investigated in a controlled trial if inspiratory muscle training could result in
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exaggerated peripheral vasoconstriction in resting and exercising limbs of subjects with
chronic heart failure. They found that after the four weeks of training with 60% of maximal
inspiratory pressure, the inspiratory muscle loading resulted into a more marked reduction in
resting calf blood flow and an attenuated rise in the exercising forearm blood flow. These
observations were attributed to inspiratory muscle baroreflex mediated by sympathetic
activation. Other significant changes observed with high intensity IMT include reduction in
resting heart rate (Gething, Passfield, & Davies, 2004; Laoutaris et al., 2004). The
mechanism behind the observed decrease in heart rate remains undetermined.
Another study by Laoutaris et al. (2008) assessed the effect of IMT on autonomic
activity, endothelial function, and N- terminal pro-brain natriuretic peptide (NT-proBNP)
levels in patients with chronic heart failure. IMT protocol included exercising at 60% (high
intensity) & 15% (low intensity) of SIPmax, three times a week for 10 weeks. All
measurements were taken before and after training, and included HRV analysis from 24-hour
ECG recording, forearm blood flow by venous plethysmography and NT-proBNP from
serum sample. High intensity IMT improved PI max and SIPmax without any changes in
HRV, endothelial function, and NT-proBNP levels. The low intensity group demonstrated
minimal increase in only the SIPmax. With a similar background, another study by the same
authors observed again that IMT did not have an effect on autonomic function (Laoutaris et
al., 2005).
The above mentioned studies were conducted on COPD or CHF subjects. IMT also
did not show any effect beyond respiratory parameters in healthy subjects (Stillings,
Gonzales, & Scheuermann, 2006). This study involved training healthy young subjects three
days per week, 30 min a day for five weeks. The intensity used was 70% PImax and it was
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gradually increased throughout training period as subjects adapted to the resistance. At the
end of training, subjects improved FVC, FEV1 and maximal voluntary contraction, but IMT
did not affect resting HR (Pre, 64 ± 2 bpm; Post, 65 ± 1 bpm), LF (Pre, 43.3 ± 7 nu; Post,
50.1 ± 4.3 nu) or HF (Pre, 46.5 ± 6.1 nu; Post, 43.7 ± 3.8 nu) components.
Contradictory to these observations, Hepburn et al. (2005) observed a significant
increase in HF peak (13.2 + 5.7 NU) and decrease in LF peak (10.2 + 5.5 NU) after six
weeks of respiratory training. Eighteen healthy subjects (age, 36 to 88 years) used a Hepburn
heart and lung exerciser (HHALE) for training. HHALE has a mouthpiece through which
the subject inspires and expires into a rebreathing bag via a filter which provides resistance to
airflow. The authors claimed that breathing the same used air increases the depth of
ventilation and eventually depth of inspiration sufficient to take in fresh air across the filter.
The resistance was gradually increased by adjusting the volume of rebreathing bag. The
protocol used for training consisted of 30-min per day, six days per week. The exact
mechanism related to these changes in HRV could not be indentified but it was proposed that
respiratory training contributed to central or peripheral mediators of HRV.
Mello et al. (2008) investigated the effect of 12-week IMT using inspiratory
resistance of 30% in six patients with CHF. They evaluated sympathetic activity by muscle
sympathetic nerve activity (MSNA), forearm blood flow by venous occlusion
plethesmography, and heart rate variability from power spectrum analysis. The results
indicated an increase in inspiratory force, a 15% reduction in MSNA (40+1 vs. 33 + 1
burst/min); an increase in forearm blood flow (0.8 + 0.1 mL/min/100g); a decrease in LF %
(45 + 5 vs. 39 + 3 Units); an increase in HF % (40 + 5 vs. 61 + 3 Units) and a decrease in
LF/HF.
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The addition of resistance during inspiration resulted in increased HRV and change in
RSA characteristics (Calabrese, Perrault, Dinh, Eberhard, & Benchetrit, 2000). This study
evaluated four conditions of resistive load breathing in seven healthy volunteers and acute
responsive changes in HRV to these conditions. A flowmeter mounted on a face mask and
connected to a differential pressure transducer was used. Four levels of resistance were
applied throughout breathing cycle, and end tidal CO2 (FCO2) and ECG were obtained
continuously for eight minutes. The resistance was created by using increasing tube
thickness connected to flowmeter and the scouring pads at the end of face mask. The
resistance was calculated by using a mouth pressure-flow plot on a breath-by-breath basis
(R0= 0.76 + 0.02 cmH2O/sec (control), R1= 3.25 + 0.16 cmH2O/sec, R2 = 5.24 + 0.30
cmH2O/sec, R3 = 8.25 + 0.37 cmH2O/sec, and R4= 12.51 + 0.63 cmH2O/sec). The results
indicated that the applying resistive loads resulted in lengthening of the respiratory period
and increase in tidal volume without any change in FCO2. Mean R-R interval remained
unchanged whereas TP, HF, LF and RCF (respiratory centered frequency spectral power
components), and RSA increased significantly with increasing load. The HRV in condition
R4 was increased to two fold that for R0. The observed increase in RSA could probably be
accounted for by either increase in intrathoracic pressure and the ensuing stimulation of
baroreceptor or changes in respiratory pattern following resistive loading.
Another study (Witt, Guenette, Rupert, McKenzie, & Sheel, 2007) observed the effect
of five week IMT (six days per week) on HR and mean arterial pressure (MAP) response to a
resistive breathing task. The resistive breathing task was designed to increase metabolic
requirements and compromise diaphragm perfusion by combing resistance and a prolonged
breath cycle. Sixteen healthy young men (age 25.8 + 0.8 years) were randomized into an
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experimental group (intensity of 50% of MIP) and a control group (intensity of 10% of MIP).
After training, the experimental group showed lower HR and MAP response than the pretraining response to resistive breathing task, while the control group demonstrated similar
response to pre-training. This observation was attributed to attenuation of sympathetic
activity and reduced activity of chemosensitive afferents within inspiratory muscles by
resistive inspiratory work.
Summary
Studies evaluating the effect of aerobic exercise and resistance exercise training
reported improved HRV. This suggests that HRV can be modified with the external
mitigating stimulus in healthy as well as clinical conditions. Currently, it is understood that
the changes in the breathing pattern influences autonomic control over cardiovascular
system. The breathing pattern can be highly manipulated voluntarily; training of some
aspects of breathing function may temporarily or permanently influence autonomic
cardiovascular modulation. IMT may provide such an option. However, studies
investigating influences of IMT on the cardiac autonomic control are limited and the results
are variable. This makes it difficult to draw inferences on the possible effects of IMT.
Different subject population within studies adds to this difficulty. The studies that yielded a
positive effect on HRV have used some forms of respiratory resistance training. It may
imply that IMT using a pressure threshold device will produce similar results. Laoutaris and
colleagues (2008) speculated that their results would have been in favor of IMT, if HRV was
measured for a shorter time at rest rather than 24 hours. There are also speculations that
more demonstrable effects may be obtained with higher intensity of IMT. Stillings et al.
(2006) speculated that the effect of IMT can be observed prominently in older adults or
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conditions associated with reduced HRV. This investigation further explores if higher
intensity, 80% of MIP, results in beneficial changes in HRV measured from short term
recording. This study also assesses the IMT induced changes in HRV, if any, in older adults
as contrasted with young adults.
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Chapter III
Methods and Procedures
Introduction
This study was designed to evaluate the effects of six weeks of inspiratory muscle
training (IMT) on the heart rate variability (HRV) in young and older adult populations. This
chapter describes the subject population as well as the design of the study. Methods and
procedures relating to the data collection, measurement techniques, training protocol and
analysis are discussed.
Description of the Study Population
The study population consisted of 12 healthy young (age 18 to 30 years) and 14 older
(age > 60 years) adults. The subjects were recruited from the community by placing
descriptors of the study at university boards, local senior centers and retirement communities.
Each subject was required to complete medical background form (Appendix B). Subjects
with a history of chronic respiratory or neuromuscular disease, previous thoracic surgery or
trauma were excluded. The subjects with body mass index (BMI) more than 40 were
excluded for the chest wall compliance limited by obesity. Potential subjects were also
excluded if they reported currently smoking, an acute infection, dementia, respiratory
disorders, dysrhythmias, unstable angina pectoris or congestive heart failure on medical
background form. Further criteria for exclusion included the current use of any heart ratealtering medications or the use of such medications within the previous year. Each subject
was determined to have an apparently healthy pulmonary function if they demonstrated
normal pulmonary function, defined as vital capacity (VC) and forced expiratory volume
(FEV1). The study was reviewed by Human Subjects Committee at Western Washington

39

University (Appendix A) and informed consent (Appendix A) was obtained from every
subject.
Design of the Study
The design of the study was a within subjects quasi-experimental design. The eligible
subjects were divided into two groups according to age, young group with adults aged 18-30
years and older group with adults aged more than 60 years. The study did not include
controls for either group. It is well established that without any intervention, HRV is stable
over months without any significant changes.
After initial evaluation, all subjects started with the inspiratory muscle training for six
weeks. At the conclusion of training, all tests to measure respiratory function and HRV were
repeated and results were compared to pre-training values.
Data Collection Procedures
Upon arrival for the initial evaluation, the procedures, any potential risks involved
and possible benefits of participation in the study were reviewed with each participant, and
the informed consent (Appendix A) was obtained.
At the initial evaluation, each subject needed to complete medical background form
(Appendix B). Each subject’s height (in centimeters) and body mass (in kilograms) were
determined using a stadiometer and balance beam scale. A physical activity log (Appendix
B) was provided to each subject to complete over three days including two weekdays and one
weekend day. This activity log assigned a kilocalorie expenditure value per kilogram body
weight in fifteen minute intervals to corresponding exertion levels of categorized physical
activities, ranging in intensities from one to nine, with one being activities such as sleep and
nine being activities such as heavy resistance exercise (Bouchard, 1997). These values were
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summed in tabular form and then converted to reveal an average daily caloric expenditure in
kilocalories using Microsoft Excel.
Instrumentation and measurement technique for pulmonary function. Each
subject was assessed for pulmonary function by measuring VC and FEV1 using a
Pneumoscan spirometer (KL engineering, Northridge, CA) and following American Thoracic
Society (1994) guidelines. All measurements were made with the subject in a sitting
position. The subject put the mouth piece mounted on the flow-meter, in their mouth and the
nose clip was secured. To measure VC and FEV1, subjects were instructed to perform a
maximal inspiration at a self selected pace and exhale with the maximal force. Three
measurements were obtained and were expressed in liters. The best trial was used in the
analysis. Maximal voluntary ventilation (MVV) was also measured using the spirometer. To
measure the MVV, the subject was required to breathe as deeply and rapidly as possible for
12 seconds. The respiratory volume value so obtained was extrapolated to one minute and
the result of the test was recorded as flow rate in liters per minute.
Maximal inspiratory pressure (MIP) was tested at the initial evaluation and then every
week during training. MIP is a useful measure of inspiratory muscle strength and it was also
used to determine the training intensity. It is measured during maximal inspiratory effort
against an occluded airway at residual volume. MIP was measured through a device
developed by the engineering staff at Western Washington University’s instrument center.
Three MIP trials were conducted in upright standing position. The highest value was
recorded in centimeters of water (cm H20) and used in analysis and determination of training
intensity.
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Before measuring MIP, a clean mouthpiece was attached to breathing hose connected
to the inspiratory pressure measuring device. The FLUKE multimeter device connected to
the inspiratory pressure measuring device was set to measure the maximum value of
inspiratory pressure. The subject stood close to the inspiratory pressure measuring box and
applied the nose clip. The mouthpiece was placed in the mouth, and then subject inhaled and
exhaled with the breathing hose valve open. Immediately following exhalation through the
breathing hose, the valve was closed when the subject indicated readiness to inhale
maximally. The subject inhaled as forcefully as possible. The multimeter displayed the
subject’s MIP value.
Instrumentation for HRV measurement. Measures of HRV were taken with a
standard 3-electrode, 1-lead electrocardiogram (ECG) setup which examined lead II.
Disposable adhesive electrodes were used for the subject-ECG interface. The ECG device
was an MP100 system (BIOPAC Systems Inc., Goleta CA) interfaced with a Pentium III
computer. AcqKnowledge software (BIOPAC Systems Inc., Goleta, CA) was used for data
recording, collection, and HRV data reduction. All HRV measurements were taken by the
same experimenter to reduce experimental error.
Measurement techniques and procedures for HRV. Subjects were instructed to
eat a light breakfast at least two hours before testing. They were also instructed to wear
clothing which would allow easy access to the wrists and ankles. Subjects were asked to lie
still and comfortably on a padded examination table in the laboratory. Every effort was made
to keep the laboratory quiet and at a comfortable room temperature. Before placing the
electrodes on the skin, the subject was presented with a simple visual analog scale (VAS)
(Data Collection Sheet, Appendix B) to rate the level of stress or anxiety at the moment. The
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procedure was not progressed until subject was comfortable and relaxed. At the post-training
ECG recording, a difference of one cm more or less than VAS score at pre-training ECG
recording was accepted. Otherwise, the post-training ECG recording was postponed and
performed another day.
The HRV test required the placement of three electrodes configured to examine lead
II. The electrode wires were color coded black (left arm [LA]), white (right arm [RA], and
red (left foot [F]) and were equipped with clips for adhesive electrodes placed at their
terminal ends. The proximal ends of the wires were plugged into the ECG port of the MP100
system. The subject’s skin at the anterior aspects of the right and left wrists, and medial
aspect of the left ankle were inspected visually for cleanliness. An alcohol swab was then
used to prep these areas for optimal ECG signal acquisition. The electrodes were clipped to
the terminal ends of LA, RA, and F wires and were placed on the medial aspects of the left
and right wrist and left ankle, respectively.
During data collection, the experimenter observed the ECG for line noise or artifacts
and abnormalities in rhythm. ECG data were recorded for five minutes. The subject was
instructed and encouraged to remain still and relaxed for the entire measurement period. If
the subject spoke or moved in any way, the test was terminated and started over.
Data processing. From the raw ECG acquisition, HRV variables were obtained with
the aid of the AcqKnowledge software which utilized algorithms conforming to frequency
domain guidelines established by the Task Force of European Society of Cardiology and The
North American Society of Pacing and Electrophysiology (BIOPAC 2007, Malik et al.
1996). The power frequency for HRV variables were defined by the task force guidelines as
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Total power (TP), < 0.4 Hz; High frequency (HF), 0.15- 0.4 Hz; Low frequency (LF), 0.040.15 Hz; Very low frequency (VLF), < 0.04 Hz.
Training procedures. IMT apparatus used for the study was a commercially
available product (PowerBreathe, Southam, Warwickshire, UK). PowerBreathe is a
pressure-threshold device which requires continuous application of inspiratory pressure
throughout inspiration in order for the inspiratory regulating valve to remain open. IMT
resistance setting was set at 80% of the MIP throughout training period. This number was
rounded down to nearest lower number on the PowerBreathe Force Chart (Appendix C) to
determine the resistance setting.
Prior to training, the subjects were familiarized with the IMT device. Training
included five sets of 12 repetitions on the IMT device five days per week for six weeks.
Subjects were instructed to breathe at a relaxed, self selected comfortable pace to discourage
hyperventilation. They were instructed to stop if they felt light headedness or nauseous.
Training sessions lasted approximately 15 minutes. Each subject was allowed a recovery
between sets. After each training session, rating of perceived exertion (RPE) values were
obtained and recorded. Any discomfort was noted. Every week the resistance setting was
adjusted to 80% of new MIP owing to the adaptation and improvement in inspiratory muscle
strength.
Training was performed in a quiet room with no distractions, and the same
instructions were given to all subjects, thereby ensuring that they were being motivated in a
consistent manner during the training period. As much as possible, IMT was performed at
the same time of the day for each session. It was emphasized that subjects do not miss more
than three sessions in six weeks.
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Data Analysis
To evaluate possible differences between pre- and post training HRV parameters and
pulmonary function measures, a two-way repeated measures analysis of variance (ANOVA)
was conducted using the factors Group (young and older) and Time (pre and post training).
HRV variables (TP, LF, HF, LFnu, HFnu, LF/HF ratio) were compared before and after IMT
within and between the two groups. The data analysis was performed with Excel 2004
(Microsoft Inc., Redmond, WA) and PAWS version 17 (Chicago, IL). The significance was
accepted at p < 0.05.
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Chapter IV
Results and Discussion
Introduction
The current study was instigated to evaluate the effects of inspiratory muscle training
(IMT) on heart rate variability (HRV) in young and older adults. HRV and pulmonary
function variables were assessed prior to and following six weeks of IMT. The current
chapter describes subject characteristics and results pertaining to data analysis from pre-and
post-training evaluations. This is followed by a discussion of these results.
Subject Characteristics
In the beginning of study, a total number of 17 young and 15 older subjects
volunteered for the study. Five of the young participants were unable to complete six weeks
of training and were excluded from the study. Results of one older subject were not included
in the study owing to higher visual analog score for stress during post-training
electrocardiogram (ECG) recording and failure to report for a second recording. As a result,
the final subject population consisted of 12 young (6 males, 6 females) and 14 older (5 males,
9 females) adults. The subject characteristics are given in Table 1.
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Table 1. Physical characteristics of subjects
Young (N= 12)

Older (N= 14)

Variable

Mean

SD

Mean

SD

Age (years)

22.25

2.13

72.5

6.44

Height (cm)

177.66

8.4

166.57

7.0

Weight (kg)

75.89

8.05

73.37

8.05

BMI (kg/m2)

23.95

2.07

26.43

3.2

Total energy expenditure (Kcal/day)

3326

722

3114

454

SD= standard deviation, BMI= body mass index
Results
Heart rate variability. The dependent HRV variables included total power (TP), low
frequency power (LF), high frequency power (HF), normalized LF (LFnu), normalized HF
(HFnu) and LF/HF ratio. These HRV variables were derived from five minute ECG
recordings obtained before and after six weeks of IMT. Every subject completed VAS to
report the level of stress at both of the recordings and the scores at both occasions were
within a permitted difference of 1-cm. Table 2 provides a descriptive summary of HRV data
among young and older subjects.
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Table 2. Descriptive data of HRV
Young
Pre-IMT

Older
Post-IMT

Pre-IMT

Post-IMT

Variable

mean

SD

mean

SD

mean

SD

mean

SD

TP (s2)

15.773

6.484

17.399

6.507

19.280

17.302

15.705

6.101

VLF (s2)

10.301

4.111

11.376

4.106

11.286

5.974

10.182

3.341

LF (s2)

4.203

1.726

4.485

1.690

5.506

6.543

4.313

2.144

HF (s2)

1.269

0.714

1.537

0.880

2.487

4.988

1.209

1.006

LFnu (nu)

0.779

0.039

0.756

0.059

0.763

0.076

0.794

0.030

HFnu (nu)

0.220

0.039

0.243

0.059

0.236

0.076

0.205

0.030

LF/HF

3.651

0.756

3.278

0.787

3.551

1.08

3.940

0.574

SD = standard deviation, TP= total power, VLF= very low frequency, LF = low frequency,
HF= high frequency, LFnu= normalized LF, HFnu= normalized HF, nu= normalized units
To assess the possible changes in the HRV variables, a two-way repeated measures
ANOVA test was used. The test revealed that there was no significant interaction between
time and group for TP, VLF, LF, and HF (p > 0.05). On further examination into main
effects for time and group, none of these variables indicated significant differences. A
significant interaction effect between time and group was observed for LFnu (F = 6.11, p =
0.02, ηp2 = 0.203) as shown in Figure 1. The main effects of time and group were examined,
but no significant effect was observed for either time (F = 0.13, p = 0.71, ηp2 = 0.006) or
group (F = 0.36, p = 0.55, ηp2 = 0.015). There was an increase of 4% and a decrease of 2% in
LFnu in the young and older group respectively.
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Figure 1. Mean LFnu in young and older groups
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LFnu = normalized LF, nu= normalized units, IMT= inspiratory muscle training
Comparison of pre-and posttest HFnu values also indicated significant interaction
effect between group and time (F = 6.11, p = 0.02, ηp2 = 0.203) (Figure 2). There was no
significant main interaction effect for time (F = 0.13, p = 0.71, ηp2 = 0.06) or group (F =6.11,
p = 0.02, ηp2 = 0.203). The young subjects demonstrated an increase of 10% in HFnu, while
the older subjects demonstrated a decrease of 13% in HFnu.
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Figure 2. Mean HFnu in young and older groups
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Similar responses were observed for LF/HF ratio where a significant interaction
effect was observed (F= 5.50, p = 0.02, ηp2 = 0.187) (Figure 3), but no significant main effect
of either time (F = 0.00, p = 0.962, ηp2 = 0.00) or group (F = 1, p = 0.32, ηp2 = 0.04). The
ratio decreased by 10% in the young adults and increased by 10% in the older adults.
Figure 3. Mean LF/HF in young and older groups
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To summarize, the significant interaction effect for LFnu, HFnu, LF/HF suggests that
the independent variables of the study (IMT and age) were not independent. Thus, it may be
proposed that the effect of IMT depended on age group or age-groups varied in their training
response to IMT. This is also indicated by the changes in the opposite direction for groups.
The changes in LFnu,HFnu and LF/HF were significant in both the groups despite opposite
training response.
Pulmonary function measures and MIP. Pulmonary function and maximal
inspiratory pressure (MIP) were evaluated before and after training to assess the effectiveness
of training regime. Pulmonary function measures included vital capacity (VC), forced
expiratory volume in 1-second (FEV1), and maximal voluntary ventilation (MVV). MIP
values measured during only pre-and post training evaluations were included in the statistical
analysis. Table 3 provides descriptive data of pulmonary function and MIP.
Table3. Descriptive data of pulmonary function and MIP
Young
Pre-IMT

Older
Post-IMT

Pre-IMT

Post-IMT

Variable

mean

SD

mean

SD

mean

SD

mean

SD

VC (liter)

4.09

1.03

4.39

1.08

2.43

0.51

2.57

0.46

FEV1 (liter)

3.35

0.95

3.64

0.84

2.02

0.42

2.08

0.42

139.75

32.91

162.66

44.43

92.42

20.58

96.42

18.67

1.06

0.33

1.68

0.38

0.72

0.24

0.98

0.14

MVV (liter/min)
MIP (cm H2O)

VC=vital capacity, FEV1= forced expiratory volume in 1-second, MVV= maximal voluntary
ventilation, MIP= maximal inspiratory pressure.
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A two-way repeated measures ANOVA test was used to compare the differences
between pre-and post-training pulmonary function measures and MIP. The test revealed that
there was not a significant interaction effect between time and group for VC (F = 0.51, p =
0.48, ηp2= 0.02), but there was significant main effect of time from pre-test to post-test (F =
4.09, p = 0.05, ηp2= 0.146) as shown in Figure 4. The young group and older group had an
increase of 7% and 5 % in vital capacity respectively. There was also significant main effect
of group (F = 33.98, p = 0.00, ηp2= 0.58).
Figure 4. Mean vital capacity in young and older groups
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When comparing FEV1, values, there was a significant interaction effect between time
and group (F= 4.40, p = 0.04, ηp2 = 0.15) (Figure 5). On further examination, the main
effects for both the group (F = 29.96, p = 0.00, ηp2= 0.55) and time (F = 11.09, p = 0.03, ηp2=
0.31) were significant. The young subjects demonstrated an increase in FEV1 by 8%, while
the older subjects improved by 3%.
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Figure 5. Mean FEV1 in young and older groups
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Similar results were observed for MVV (Figure 6) where there was a significant
interaction effect (F = 11.13, p = 0.00, ηp2= 0.31) followed by significant main effect of time
(F = 22.54, p = 0.00, ηp2= 0.48) and group (F = 24.28, p = 0.00, ηp2= 0.50). The overall
increase in MVV was 16% in the young group and 4% in the older group.
Figure 6. Mean MVV in young and older groups
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ANOVA test results for maximal inspiratory pressure revealed significant interaction
effect between time and group (F = 14.65, p = 0.00, ηp2= 0.379). The main effects were
examined and were found significant for time (F = 93.10, p = 0.00, ηp2 = 0.795) and group (F
= 24.72, p = 0.00, ηp2= 0.50) (Figure 7). The young group demonstrated an increase of 50%
in MIP, while the older group demonstrated an increase of 37%.
Figure 7. Mean MIP in young and older adults
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To summarize, the significant main effect of time for VC is consistent across groups
implying no interaction effect. The significant main effect of group, backed by the greater
increase in means for the young group, reveals significantly greater improvement in VC for
the young group as opposed the older group. For FEV1, MVV, and MIP, a significant
interaction was observed indicating that the effect of IMT depended on the group. However,
the significant main effects for both the time and group further revealed that the improvement
in FEV1, MVV, and MIP was significantly greater in the young group as opposed to the older
group.
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Discussion of Results
The current investigation compared changes in HRV measures in the young and older
adults after six weeks of IMT. The significant changes in LFnu, HFnu and LF/HF between
and within the young and older group (p < 0.05) showed that there was a training effect of
IMT. However, there were no significant changes in TP, LF and HF (p > 0.05). Therefore,
the null hypothesis that there will be no difference in HRV measures before and after IMT
cannot be completely rejected. Similarly, the other null hypothesis that there will be no
difference in responses from both the groups cannot be rejected.
Because VLF cannot be measured accurately from short term recordings, LF and HF
are also reported in normalized values which represent the relative values of each power
component in proportion to the total power minus VLF component. Normalization tends to
control the effect of changes in total power on the values of HF and LF (Malik et al., 1996;
Sandercock & Brodie, 2006). Thus, normalized LF and HF reflect the changes in HRV
profile more effectively. A significant training effect of IMT is apparent in both the young
and older adults for these variables.
The VLF component is not heavily evaluated due to its physiological correlates being
largely unknown. The high frequency component (HF) is parasympathetically mediated
(Akselrod et al., 1981; Pomeranz et al., 1985; Raeder et al., 1987), and the LF component is
influenced by both sympathetic and parasympathetic nervous activity (Akselrod et al., 1981;
Pomeranz et al., 1985; Raeder et al., 1987; Saul, 1990). There is no known method of
precisely determining the contribution of each branch with the LF power spectra. LF/HF is
an indicator of the sympathetic-parasympathetic balance in autonomic nervous system
(ANS). The decrease in LF/HF in the young adults is attributed to relatively greater increase
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in HF when compared to the increase in LF. The culmination of such results may imply a
shift in balance towards parasympathetic modulation. In older adults, LF/HF increased
despite simultaneous non-significant decrease in both LF and HF. These observations may
suggest that IMT resulted in a shift in balance away from parasympathetic modulation.
Currently, there are no other known IMT studies evaluating the simultaneous effect of
IMT on HRV in similar age groups. In addition, the available studies used different
populations and different methods to evaluate HRV, making the comparison of results from
the current study difficult. Stillings, Gonzales, & Scheuermann (2006) evaluted HRV in
healthy young adults (age 25 +5 years) prior to and follwing a five weeks IMT (70% MIP, 3days/week, 30 min/day) and found no significant changes in resting heart rate, normalized LF
or normalized HF. The investigations by Laoutaris et al. (2008) and Mello et al. (2008)
included subjects with chronic heart failure. Laoutaris and colleagues demonstrated no
singificant changes in time and frequency domain HRV variables obtained from 24- hour
ambulatory ECG monitoring after 10 weeeks of IMT (3-days/week). On the other hand,
Mello et al. (2008) observed a significant decrease in LF, increase in HF and decrease in
LF/HF ratio. The study used 12-week IMT at 30% MIP, however the training protocol and
method of HRV measurement are not available for further comparison.
The exact meachanism attributable to the observed changes in HRV profile is not
well established and is beyond the scope of the current study. The speculations may include
attenuation of sympathetic activity through reduced activity of chemosensitive afferents
within fatigued inspiratory muscles by resistive inspiratory work (Witt et al., 2007). The
IMT protocol in the current study used an intensity of 80% of MIP. The rating of perceived
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exertion for both the groups ranged from 13 to 15. It may be suggested that the IMT protocol
was able to induce fatigue in inspiratory muscles.
Calabrese et al. (2000) demonstrated that breathing under resistive loading resulted in
breathing pattern changes. While breathing in against resistance, the most of subjects in both
the groups decreased the rate and increased the depth of breathing. Respiration is strong
modulator of autonomous nervous system and HRV is influenced by the rate and depth of
breathing by affecting the phasic inputs from pulmonary and thoracic stretch receptors. It is
suggested that these phasic inputs from pulmonary and thoracic stretch receptors make small
but statistically significant contribution to respiratory sinus arrhythmia (RSA) (Davidson,
Goldner, & McCloskey, 1976; Davis, McCloskey, & Potter, 1977; Elghozi et al., 1991).
Hirsch and Bishop (1981) have demonstrated increase in RSA with decrease in breathing rate
and associated decrease in receptors phasic inputs. RSA is primary contributor to the high
frequency component of HRV that occurs at respiratory frequency > 0.25 Hz (Bernardi et al.,
1989; Kleiger et al., 2005; Pumprla et al., 2002). Brown et al. (1993) observed that R-R
interval power in LF and HF spectra declined significantly with higher breathing frequency
and vice versa. Thus, it may be suggested that change in breathing rate during IMT had a role
in affecitng HF spectra of HRV.
As the subject population in the current study showed a small heterogeneity of
responses, it would be valuable to identify factors that are likely to be responsible for these
differences. The older adults demonstrated higher mean values of TP, VLF, LF and HF, and
lower mean LF/HF ratio at the beginning of the study. However, the between-group
differences were not significant. This contrasts the common observation in previous studies
that demonstrated decline in HRV with age (Schwartz, et al., 1991; Shannon et al., 1987;
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Yeragani et al., 1997). These studies observed lower frequency domain HRV variables in
older adults when compared to young adults. The possible explanation for the higher values
in older subjects is that the most of older subjects were recruited from adult fitness program
at Western Washington University and were moderately trained in aerobic and resistance
exercises. The observations from the studies reviewed previously have indicated greater
HRV in trained individuals (Melo et al., 2005; Rennie et al., 2003). It is also well established
that HRV increases with regular aerobic exercises of moderate intensity (Buchheit et al.,
2004; Sandercock et al, 2007; Tulppo et al., 2003). There are also investigations that have
established increase in HRV with resistance training (Figueroa et al., 2008; Selig et al.,
2004). Thus, the training status of older adults may have favored towards higher HRV.
When the mean total energy expenditure for both the groups were compared, no significant
differences were revealed (p > 0.05). Carter et al. (2003) have observed that older adults
have greater training potential to improve HRV than the young adults in response to same
aerobic exercise training. Thus, it may be proposed that the older adults in the current study
might have exhibited greater training response from the physical activity.
The other confounding factor is the time of ECG recording from the previous
exercise. The time of ECG recording at pre-and post training evaluations and previous
exercise activity was not actively controlled. Some of the older adults reported for their
initial evaluation and ECG recording after they finished their regular scheduled 30-45
minutes long aerobic exercise session. The average time that elapsed between the exercise
and ECG recording ranged from 45 minutes to an hour. Thus, sympathetic excitation and
parasympathetic withdrawal associated with exercise might have influenced HRV data.
However, it has been show that autonomous nervous system activity recovers to its pre-
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exercise state within 30 minutes after exercise. These studies investigated the HRV during
recovery from 30 to 40 minutes of moderate aerobic exercises and observed that the least
time to recover HRV ranged from 15 minutes to 60 minutes (Gladwell, Sandercock, & Birch,
2010; Heffernan, Kelly, Collier, & Fernhall, 2006; Seiler, Haugen, & Kuffen, 2007). These
observations are often contradicted by studies that observed altered autonomous nervous
system as long as 24 to 48 hr after moderate to vigorous exercise (Hautala, 2001).
A recent study by Mendonca et al. (2010) demonstrated that women, compared to
men, have greater parasympathetic input for cardiac autonomic function during rest and
recovery from exercise. The study observed lower LF, higher HF and lower LF/HF ratio in
women. The older group had proportionally higher number of females. Also, the larger
standard deviations in the older group indicate the wide variations within the group. These
facts may have contributed to the heterogeneity in responses.
The pulmonary function measures and MIP test results indicate that IMT was
effective in improving not only inspiratory muscle strength, but also pulmonary function
measures. This observation is consistent with other research using similar training protocol
(Stillings et al, 2008; Gething et al., 2004). The young adults demonstrated higher increases
in VC, FEV1, MVV and MIP when compared to older adults. The between-group
differences for these variables were statistically significant. The statistically significant
increases of 58% and 37% in MIP in young and older adults respectively, suggest that six
weeks of IMT was a successful training program.
Limitations. The current study has several limitations. First, the subjects voluntarily
participated for the study with the interest of improving lung function. The non-randomized
selection of subjects and their underlying interest of participation might have confounded the
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results. Secondly, the subject’s efforts pose another limitation as the subject had to put forth
maximal effort during MIP and pulmonary function evaluations. The third limitation is posed
by the subject’s familiarity and comfort with testing procedures at the post-training
evaluations.
The subjects were instructed to keep same exercise routine. The possible change in
physical activity despite the advice was not actively assessed during the period of training.
This poses another limitation to analysis of the results.
The time of the day when subjects completed the ECG recordings for pre-and posttraining evaluations, was not essentially the same at the two occasions. Another important
limitation is that the respiration rate was not controlled during ECG recording. There is no
common agreement over controlled respiration rate during ECG recording. HRV can be
adversely affected when the subjects attempt to control breathing at a rate set by metronome.
Lastly, the number of IMT devices available for training was limited and the training
period of older group followed the training period of the young group. The training of the
young subjects was completed mostly in Spring season, while that of older subjects extended
into Summer. The seasonal influence on HRV is not unknown and may have confounded the
results. The systematic difference in the calibration of the equipment over different time
spans of training poses limitation of instrumentation error.
Summary of Results
Results of the current study demonstrate significant changes in LFnu, HFnu and
LF/HF following six weeks of inspiratory muscle training. IMT did not appear to influence
LF, HF, and TP in both the young and older groups. The training response varied between
both the groups. A significant increase in strength of inspiratory muscles and pulmonary
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function measures occurred in both the groups with the young group demonstrating greater
training response.
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Chapter V
Summary, Conclusions, and Recommendations
Summary
The purpose of this study was to investigate the effect of inspiratory muscle training
(IMT) on heart rate variability. The study population consisted of 26 apparently healthy
subjects (12 young, 14 older). Every subject had to complete a medical background form
and physical activity log. The before and following training assessments included pulmonary
function tests (VC, FEV1, MVV) and five minutes recording of electrocardiogram (ECG).
The dependent HRV variables (TP, LF, HF, LFnu, HFnu and LF/HF) were obtained from
ECG recordings using AckKnowledge software. IMT protocol included five sets of 12
repetitions, five days per weeks for six weeks. The intensity for training was kept constant at
80% of maximal inspiratory pressure (MIP) by adjusting the resistance of the IMT device
every week owing to the adaptation and improvement in inspiratory muscle strength as
determined by MIP.
At the conclusion of six weeks of IMT, it was demonstrated that there was significant
difference in pre-and post-training values of LFnu, HFnu and LF/HF ratio in both the groups.
No significant effect was observed for TP, LF and HF. The training response varied between
groups. The pulmonary function measures (VC, FEV1, MVV) and MIP demonstrated
significant increases in both the groups.
Conclusion
Results from this investigation indicate that six weeks of inspiratory muscle training
had a significant effect on LFnu, HFnu and LF/HF ratio in both the young and older groups.
The other variables TP, LF, and HF did not demonstrate any significant changes. However,
the training response depended on group and varied within groups. The young group
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demonstrated a shift in autonomic balance towards parasympathetic modulation, while the
older group demonstrated decrease in parasympathetic modulation. The determination of
exact mechanism is beyond the scope of this study. It may be proposed that IMT was
associated with respiratory modulation of ANS, which was then reflected in changes in HRV
profile. The results also demonstrated improved inspiratory muscle strength and pulmonary
function measures in both the groups, where the young group experienced greater
improvement than older group.
Recommendations
A high HRV is a sign of good adaptability. Any attempt to increase HRV is
beneficial in many clinical conditions as well as health. The current study adds to the
literature to better understand the effects of IMT on HRV. More investigations are needed to
elaborate and examine the typical effects IMT can produce on HRV profile.
Recommendations for future research include:
1. Perform same or a similar study with larger subject pool.
2. Control precisely physical activity changes over the period of training.
3. Control precisely the time between ECG recordings and the previous exercise session.
4. Minimize influence of season by controlling the time of training and prevent systematic
effects by having the two groups evaluated at the same time.
5. Perform same or a similar study using different subject population with diagnosed clinical
conditions associated with low heart rate variability.
6. A longer duration of IMT may produce different results.
The recommendations for clinical application of IMT include use of a similar IMT
protocol to increase inspiratory muscle strength and pulmonary function. The observations

63

from pulmonary function tests and MIP results are applicable to a wide range, from healthy
to clinical subject population. The associated HRV changes need to be explored further, to
facilitate the use of IMT to improve HRV.
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INFORMED CONSENT STATEMENT
Western Washington University
Physical Education, Health and Recreation Department
Title: The Effect of Inspiratory Muscle Training on Heart Rate Variability
Print Name: _____________________________________________________
The purpose of this study is to determine the effect of inspiratory muscle training (IMT) on
measures of heart rate variability (HRV) in young and older adults. This study will
contribute to the limited existing literature on the possible positive effects of IMT on heart
rate variability. This study will also investigate the difference in response to IMT in young
and older adults. The benefit of this research is that the subjects may develop increased
inspiratory muscle strength and pulmonary function allowing improvement in exercise
capacity and tolerance.
Before beginning of the program you will be required to complete a medical background
check. If you have any relevant medical or physical limitations, you may not be eligible to
participate in this study. You will be required to perform a pulmonary function test and
maximal inspiratory pressure test (MIP) that evaluates lung parameters. These simple tests
require subjects to inhale and/or exhale deeply and forcefully. You may not be eligible for
study if your pulmonary test values do not fall within normal range.
The baseline data will be collected the first week of study and again during the last week of
the study. The testing procedures will take place in the Physiology Lab (CV 210). In
addition to previously mentioned data, your height and weight will be measured on
stadiometer and balance beam scale. A five minute electrocardiogram (ECG) recording will
be obtained with you lying comfortably on the cushioned table. You will be required to
answer to a visual analog scale before the investigator starts the ECG recording. To allow
analysis of caloric expenditure, you will be required to fill out a three-day physical activity
record. A familiarization session will take place prior to training to explain the use of IMT
device.
All participants will be required to complete six weeks of inspiratory muscle training using
an IMT apparatus. It is a pressure-threshold device which requires continuous application of
inspiratory pressure throughout inspiration in order for the inspiratory regulating valve to
remain open. You will be required to use IMT device five days per week for six weeks. The
approximate time for each session is 10 to 15 minutes. You should not miss more than three
sessions to continue participation in the study. Every week, the MIP test is repeated to allow
readjusting the resistance at a persistent load of 80% of MIP.
As with any exercise, muscle fatigue may be experienced. There are very minimal
discomforts associated with pulmonary function test and IMT training. You may feel
dizziness, light headedness, exhaustion during breathing maneuvers. All proper procedures
will be taken to reduce these discomforts including testing and training in sitting positions,
adequate rest between sets and close monitoring of participants. The training device requires
subjects to use mouthpiece to blow into apparatus. The investigator will ensure that all
mouthpieces used are cleaned between subjects to prevent cross-contamination. The ECG
recording requires putting electrodes on subject’s skin. A new set of electrodes will be used
for every subject.
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All subjects will be assigned a reference number to assure that all records will be kept
confidential. All records and signed documents will be kept in separate files that will be
accessed only by reference number. Data for each individual from each testing session will
not be shared with other subjects.
Subject questions and concerns will be initially addressed during the orientation session and
subjects should feel free to ask questions and voice concerns as the study progresses.
Your participation in this study is greatly appreciated. This participation is voluntary and
you may withdraw yourself from participation at any time.
If you have any questions or comments during the course of the study please contact me at
425-614-9694 or email choudha@students.wwu.edu or Dr. Lorrie Brilla at 360-650-3056 or
Lorrie.Brilla@wwu.edu. I will answer any questions you may have concerning the
procedures. If you have any questions about you participation or your rights as a research
participant, you can contact WWU Human Protections Administrator, (360) 650-3220.
Investigator: Anuja Choudhari
________________________________________________________________________
I have read and understand the procedures for the study described above. I am aware of the
potential risks and I agree to participate as a subject in the study described above. I
understand that I may withdraw from participation at any time during the course of the
investigation.
Subject Signature: ________________________________ Date: _________________
A copy of the consent from will be provided to each subject.
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Human Subjects Activity Review Form
Investigator: Anuja Choudhari
1. What is your research question, or specific hypothesis?
The purpose of this study is to investigate the effect of inspiratory muscle training
(IMT) on the heart rate variability (HRV) in young and older adults. The null
hypothesis is that there will be no significant difference between pre and post
measures of heart rate variability after six weeks of IMT training in young and older
adults. Additionally, it is hypothesized that both young and older group will exhibit
similar response to training relative to HRV changes, if any.
A reduced HRV has been identified as a strong predictor of risk related to the adverse
events in healthy individuals and patients with a large number of diseases. An attempt
to improve and possibly correct the autonomic imbalance will substantially decrease
the mortality (Kleiger, Miller, Bigger, & Moss, 1987). Given the modulatory effect of
breathing on the heart rate variability, IMT may provide an effective intervention to
increase the heart rate variability. But, the effect of inspiratory muscle training on
HRV has not explored much in the literature and thus warrants further
experimentation.
2. What are the potential benefits of the proposed research to the field?
Most of literature on IMT is restricted to its application in improving the respiratory
dynamics in health and disease. The studies are very limited that examined the
possible effects of IMT on the autonomic nervous system. Given the scarcity of
literature, the potential benefits of this study include adding to scant literature
regarding the effects of IMT on cardiac autonomic control. This study also allows
exploring differences, if any, in young and older adults in their training response to
IMT in terms of autonomic regulation.
3. What are the potential benefits, if any, of the proposed research to the subjects?
As a benefit of participation, the subjects will individually receive pulmonary
function information and six weeks of monitored inspiratory muscle training. IMT
has been shown to improve the pulmonary function and inspiratory muscle strength
by training inspiratory muscles against resistance (Inbar, Weiner, Azgad, Rotstein, &
Weinstein, 2000; Volianitis et al., 2001). This in turn may benefit the subjects to
improve their exercise capacity and tolerance. A positive change in HRV, if observed,
will be beneficial to subjects as it represents greater ability to adapt to stressors.
4. a) Describe how you will identify the subject population, and how you will contact
key individuals who will allow you access to that subject population or database
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The young subject population will be pooled from those who volunteer either based
on responses to flyers around Western Washington University campus or from
announcements made in Kinesiology and Physical Education classes. The older
subject population will be pooled from healthy and active community dwelling older
adults who responded to the descriptors of the study at local senior centers and
retirement communities. The investigator will then contact the interested individuals
to explain the study, its duration or expected time involvement, information regarding
IMT and the benefits to be expected from performing this study.
b) Describe how you will recruit a sample from your subject population, including
possible use of compensation, and the number of subjects to be recruited.
The study population will consist of approximately twelve healthy young (age 18 to
30 years) and twelve older (age > 60 years) adults. All interested subjects will
complete a medical background (See Attached) and a pulmonary function test. The
medical background will be used to identify and exclude any subjects with history of
chronic respiratory or neuromuscular disease, previous thoracic surgery or trauma.
Potential subjects will be excluded if they are current smokers, had acute infection,
dementia, respiratory disorders, dysrhythmias, unstable angina pectoris or congestive
heart failure. Further criteria for exclusion include the current use of any heart ratealtering medications or the use of such medications within the previous year. Each
subject will complete the pulmonary function test to determine vital capacity (VC)
and forced expiratory volume for 1 second (FEV1). The subjects will be excluded if
they do not demonstrate normal VC and FEV1.
The first twelve subjects to respond and determined apparently healthy from the
medical background and pulmonary function values will be chosen from each of the
older and young subject pool. The remainder will be held in a reserve pool to replace
any drop outs. Each subject will be provided with six weeks of inspiratory muscle
training. No other compensation will be used.
5. Briefly describe the research methodology. Attach copies of all test
instruments/questionnaires that will be used. Note: All attachments must be in final
form; drafts are unacceptable.
The first day of the study will consist of orientation and preliminary testing conducted
at the Carver Gym Physiology Laboratory of Western Washington University. The
orientation will include a thorough explanation of testing and training procedures.
The participants will be provided with the informed consent document (See
Attached).
The baseline data will be collected prior to beginning of training. The baseline data
includes: height, measured by stadiometer converted from quarter inch to the nearest
centimeter units (2.54 cm = 1 inch), weight, using a balance beam scale with
measurements converted to kilograms (2.2 lbs=1 kg), and the pulmonary function test
using a Pneumoscan spirometer (KL engineering, Northridge, CA). VC and FEV1
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will be measured three times, following guidelines from American Thoracic Society
guidelines (1994). The subjects are instructed to inhale maximally and exhale with
maximal force through the mouthpiece mounted on Pneumoscan flowmeter. The
highest value will be noted. All measurements will be made with subjects in sitting
position. Additionally, maximal voluntary ventilation (MVV) will be measured using
Pneumoscan spirometer. MVV is measurement of maximal amount of air subject
breathes when breathing as deeply and as quickly as possible over the period of 12
seconds.
Maximal inspiratory pressure (MIP) reflects the force-generating ability of the
combined inspiratory muscles and it is measured during maximal inspiratory effort
against an occluded airway at residual volume. MIP will be measured through a
device developed by the engineering staff at Western Washington University’s
instrument center. Three MIP trials will be conducted in upright standing position and
the highest value will be recorded in centimeters of water (cmH20). It will be assessed
to provide a baseline for IMT training and it will be repeated every week to ensure a
persistent training load.
All measurements will be taken by the same experimenter to reduce experimental
error. Precise instructions for each subject will be enforced to ensure consistency for
pulmonary function and HRV measurements. Prior to the HRV measurement, all
subjects will be asked to refrain from vigorous exercise for at least 24 hours. They
will also be instructed to wear clothing which would allow easy access to the wrists
and ankles
Measurements of HRV will be collected via five minute electrocardiogram (ECG).
Subject will be asked to lie still and comfortably on the padded table. Every effort
will be made to keep the area quiet and at a comfortable room temperature. The
subject will then respond to visual analog scale (VAS) that will be used to monitor
the level of stress or depression at the time of ECG recording. VAS is a 10-cm scale
where left end represents no stress/depression and the right end represents maximum
stress/depression. The subject will put a mark on the scale relating to level of stress or
depression. The distance from left end will be measured and recorded. This data will
be used to compare the stress/depression level at the pre- and post-training ECG
recordings. At the post-training ECG recording, a difference of no more or less than
one in VAS scores is acceptable. In the case of difference, the post-training ECG
recording will be postponed and performed later another day. A standard 3-electrode,
1-lead ECG setup which examined lead II will be used. Disposable adhesive
electrodes will be used for the subject-ECG interface. The electrode placement sites
on the skin are the medial aspects of the right and left ankles, and the anterior of right
wrist. All skin sites will be inspected visually and cleaned with alcohol swab prior to
electrode placements. The subject is instructed to stay still and quiet until examiner
indicates the end of test. The subject is reminded that they can freely interrupt test in
case of any discomfort. The ECG device is an MP100 system (BIOPAC Systems Inc.,
Goleta CA) interfaced with a Pentium III computer. AcqKnowledge software
(BIOPAC Systems Inc., Goleta, CA) will be used for data processing and data
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reduction into HRV variables according to the guidelines established by the Task
Force of European Society of Cardiology and The North American Society of Pacing
and Electrophysiology (Malik et al. 1996).
Each subject will be required to complete a three day physical activity log (see
attached). This activity log will be used to assign a kilocalorie expenditure value per
kilogram body weight in fifteen minute intervals to corresponding exertion levels of
categorized physical activities, ranging in intensities from one to nine, with one being
activities such as sleep and nine being activities such as heavy resistance exercise
(Bouchard, 1997). These values are summed in tabular form and then converted to
reveal an average daily caloric expenditure in kilocalories using Microsoft Excel.
The IMT protocol includes five sets of 12 repetitions on IMT device five days per
week for six weeks. An adequate recovery will be allowed between sets. IMT
resistance setting for each subject will be determined by using 80% of his/her highest
MIP value. Every week MIP will be reassessed and the training load will be
readjusted to 80% of MIP. After each adjustment in training load, rate of perceived
exertion (RPE) values will be obtained and any discomfort will be noted. Same
instructions will be given to all subjects, thereby ensuring that they are being
motivated in a consistent manner during the training period. As much as possible,
IMT will be performed at the same time of the day for each session. After completion
of training, pulmonary function test and HRV measurement will be repeated.
6. Give specific examples (with literature citations) for the use of your test
instruments/questionnaires, or similar ones, in previous similar studies in your field.
Measurement and analysis using ECG to computer interface is widely used in studies
which examine heart rate variability. Studies by Carter et al. (2003), Sandercock,
Grocott-Mason, and Brodie (2007) examined the effects of exercise on HRV using
such instrumentation. A few studies including Calabrese et al. (2000) & Stillings,
Gonzales, Scheuermann (2006) have used similar instrumentation to assess changes
in HRV in response to respiratory muscle training. Short term HRV measurement has
also been used in previous study at Western Washington University (Barlond, 2009)
and had been approved by the university human subjects committee.
IMT apparatus used for the training the inspiratory muscles is a commercially
available product (PowerBreathe, Southam, Warwickshire, UK). PowerBreathe is a
pressure-threshold device which requires continuous application of inspiratory
pressure throughout inspiration in order for the inspiratory regulating valve to remain
open. It has been used in previous studies at Western Washington University (Feutz,
2006; Jackson, 2008; Hahn, 2010).
7. Describe how your study design is appropriate to examine your question or specific
hypothesis. Include a description of controls used, if any.
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Heart rate variability reflects the interaction of the sympathetic (SNS) and
parasympathetic nervous systems (PNS) to control heart rate (Akselrod, et al., 1981;
Pagani, et al., 1986) and provides a powerful tool to investigate cardiac automic
control. It is considered inexpensive, simple to use, and is also considered as accurate
and reproducible. It is extensively used within research, however only a few studies
have used in association with IMT. Similar IMT protocol is widely used in studies
(Chiappa et al. 2008; Gething, Passfield, & Davies, 2004). There is no control group
against any of the two study groups. HRV remains stable without any significant
changes over months unless there is an intervention (Buchheit, et al., 2004; Melanson
& Freedson, 2001; Tulppo, et al., 2003).
The design of study is within subjects quasi-experimental design. The two groups
consisted of young and older eligible subjects. Comparisons will be made from
baseline, between and within groups for HRV variables that included total power
(TP), high frequency power (HF), normalized HF (HFnu), low frequency power (LF),
normalized LF (LFnu), and LF/HF ratio. The data analysis will be performed with
Excel 2004 (Microsoft Inc., Redmond, WA) and PAWS version 17 (Chicago, IL).
The significance will be accepted at p < 0.05.
8. Give specific examples (with literature citations) for the use of your study design, or
similar ones, in previous similar studies in your field.
Stillings, Gonzales, & Scheuermann (2006) examined the effect of inspiratory muscle
training on HRV in healthy young subjects using a pre-post treatment design. The
training included 30-min sessions, three days per week, for five weeks at an intensity
of 70% maximal inspiratory pressure (PImax). The intensity was gradually increased
throughout training period as subjects adapted to the resistance. The results however
did not observe any effect on HRV.
Another study by Laoutaris et al. (2008) assessed the effect of IMT on autonomic
activity, endothelial function, and N- terminal pro-brain natriuretic peptide (NTproBNP) levels in patients with chronic heart failure. IMT protocol included
exercising at 60% of SIPmax, three times a week for 10 weeks. All measurements
were taken before and after training and included HRV analysis from 24-hour ECG
recording, forearm blood flow by venous plethysmography and NT-proBNP from
serum sample. High intensity IMT improved PI max and sustained maximal
inspiratory pressure (SIPmax), but HRV, endothelial function, and NT-proBNP levels
were not altered.
Mello et al. (2008) investigated the effect of 12 week IMT using inspiratory
resistance of 30% in patients with CHF. They evaluated sympathetic activity by
MSNA, forearm blood flow by venous occlusion plethesmography, and heart rate
variability from power spectrum analysis. The results indicated a decrease in LF, an
increase in HF, and a decrease in LF/HF ratio.
In exercise science, repeated measures designs are popular and used regularly to
assess human performance across multiple conditions. It is felt that evaluating using a
within subjects design or even a single subject design, allows for a stronger
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interpretation of the interventions at the individual level. Schutz et al. (1987) has
provided guidance for many exercise science researchers utilizing a within subject
design, and Bates (1996) highlights many of the problems assessing human
performance using randomized, fixed designs.
9. Describe the potential risks to the human subjects involved.
The risks associated with the evaluation using pulmonary function test and ECG
recording are very minimal. Subjects may feel light headedness or dizziness during
the pulmonary function tests. When using PowerBreathe, subjects may feel little
discomfort in chest wall and may feel exhausted. These discomforts often lessen as
subject progress through training. Subjects are required to use mouthpieces and nose
clips to inspire through the apparatus potentiating risk of cross-contamination.
10. If the research involves potential risks, describe the safeguards that will be used to
minimize such risks.
During the ECG measurements, participants in this study will be lying down supine,
still and quiet. The examination table will be at a height which allows each subject to
easily translate to and from standing and lying positions. A new set of disposable
adhesive-interfaced electrodes will be used for each subject. The pulmonary function
tests will be performed in sitting position and every subject will be closely monitored
during tests. The mouthpieces and nose clips used during tests and training, will be
cleaned after each use to reduce risk of cross-contamination. Cleaning will consist of
an initial rinsing of instruments with warm water, followed by submersion into 10%
bleach solution and Alconox, a biodegradable laboratory detergent. The mouthpieces
will be then rinsed and allowed to air dry. Every subject will be familiarized with
PowerBreathe before beginning of training to ensure proper posture and technique.
11. Describe how you will address privacy and/or confidentiality.
Subjects identifiable information will be undisclosed during the study. During the
presentation of this study, the participant data will be devoid of names or otherwise
identifying features, and instead will include only a subject number in order to ensure
confidentiality and anonymity. At no point will an individual’s identifiable data be
released to public sources. All data will be maintained electronically and hard copy in
a cabinet in a locked room.
12. N/A
13. N/A
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Appendix B
Medical background
Physical Activity log
Data collections sheet
Training record
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Medical background
Name: __________________________________________________ Subject Number: ____
Age: _____________ Sex: _______
Phone number: __________________
Emergency Contact Name: __________________________________
Emergency Contact Phone Number: ___________________________
Have you diagnosed with any of the conditions below? If so, place check by the
condition, and provide a date (month/year) of diagnosis by medical professional.
Condition

Month/Year

Condition

Asthma

Hypertension

Bronchitis

Ischemic heart disease

COPD

Myocardial infarction

Pneumonia

Congestive heart failure

Pleural effusion

Arrhythmia

Tuberculosis

Arterial disease

Rheumatic fever or arthritis

Unstable angina

Dementia

Valvular disease

Parkinson’s disease

Stroke

Multiple sclerosis

Other (please list)

Month/Year

Poliomyelitis

Please describe any medications you are taking. List the medications and describe the
condition.
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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Please describe any drug allergies that you are aware of:
___________________________________________________________________________
___________________________________________________________________________
Please describe any spring allergies:
___________________________________________________________________________
___________________________________________________________________________
List any surgical interventions, hospitalizations for severe injuries, and disabilities. Please
include moth and year.
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Have you ever smoked?

Yes or No (circle one)

If yes, are you still smoking? Yes or No (circle one)
If you have quit, when did you quit? ____________

Do you consume caffeine and/or alcohol? How often and how much do you drink?
___________________________________________________________________________
___________________________________________________________________________
How much sleep do you average in one night? Do you wake up feeling rested in the
morning?
___________________________________________________________________________
___________________________________________________________________________
Do you exercise? How often and how long do you exercise for? What kind of exercises do
you do?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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Physical activity log
Use this form to record daily physical activities from hour to hour over three days. Please
include two weekdays and one weekend day.
Name: ________________________________________
Start date/day: ____________________
End date/day: ____________________
DAY:
TIME

Mid
night
1:00
am
2:00
am
3:00
am
4:00
am
5:00
am
6:00
am
7:00
am
8:00
am
9:00
am
10:00
am
11:00
am

ACTIVITY
0-15
min

16-30
min

TIME
31-45
min

46-60
min

Noon
1:00
pm
2:00
pm
3:00
pm
4:00
pm
5:00
pm
6:00
pm
7:00
pm
8:00
pm
9:00
pm
10:00
pm
11:00
pm

(Actual log included two more sheets as given here.)
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ACTIVITY
0-15
min

16-30 31-45 46-60
min
min
min

Data Collection Sheet
Date:

Pretest / Post-test

Name: ________________________________________________ Subject number:
Age:

____________

Height: ____________________________________
Weight: ____________________________________
BMI:

___________

Maximal Inspiratory Pressure (MIP): ____________
Trial 1
Trial 2
Trial 3
Maximal voluntary ventilation (MVV): ____________
Vital capacity (VC):

____________

Forced expiration volume (FEV1): ________________
Trial 1
Trial 2
Trial 3

VC

FEV1

Visual Analog Scale:
No
Stress /Depression

Maximum
Stress/ depression

Respiratory rate:
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TRAINING RECORD
Subject Number:

WEEK
week 1

TRAINING LOAD POWERBREATHE
( 80% MIP)
POSITION

DAY
day 1

COMMENTS
2
3
4
5

MIP
week 2

Trial 1:

Trial 2:

Trial 3:
day 1
2
3
4
5

MIP
week3

Trial 1:

Trial 2:

Trial 3:
day 1
2
3
4
5

MIP
week 4

Trial 1:

Trial 2:

Trial 3:
day 1
2
3
4
5

MIP
week 5

Trial 1:

Trial 2:

Trial 3:
day 1
2
3
4
5

MIP
week 6

Trial 1:

Trial 2:

Trial 3:
day 1
2
3
4
5

MIP

Trial 1:

Trial 2:

Trial 3:
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Appendix C
PowerBreathe Force Chart
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Powerbreathe Force Chart

Position

Voltage

cm H2O

1

0.196

19.6

1.5

0.316

31.6*

2

0.436

43.6

2.5

0.582

58.2*

3

0.728

72.8

3.5

0.893

89.3*

4

1.058

105.8

4.5

1.150

115.0*

5

1.241

124.1

5.5

1.412

141.2*

6

1.583

158.3

6.5

1.869

172.6*

7

1.989

186.9

7.5

2.109

198.9*

8

210.9

8.5

222.9*

9

235.0*

9.5

247.0*

10

260.9*

* = Estimated values
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Appendix D
Raw subject data
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Descriptive subject characteristics
Young group
Subject Age
#
(years)
2
20
3
21
4
22
5
24
7
22
9
20
12
22
13
20
14
25
15
22
16
22
17
27

Sex
F
M
M
F
M
F
M
F
M
F
M
F

Height
(cm)
166
192
184
175
175
175
181
172
187
174
186
165

Pre-weight
(kg)
73.93
92.53
87.99
71.66
76.65
81.19
75.29
64.18
77.79
63.95
87.54
58

PostBMI
weight (kg) (kg/m2)
76.65
26.83
87.99
25.10
86.63
25.99
71.66
23.40
77.56
25.03
80.28
26.51
75.29
22.98
61.68
21.69
75.74
22.25
63.95
21.12
86.18
25.30
58.8
21.30

TEE
(Kcal)
3324.81
3706.68
4175.75
3527.58
3026.63
3215.41
2250.42
2567.54
3582.37
3485.28
4717.08
2336.00

Height
(cm)
172
174
165
165
169
162
152
166
159
168
181
162
166
171

Pre-weight
(kg)
90.71
69.39
66.67
73.02
82.1
71.21
63.5
52.61
68.94
86.63
76.2
65.31
77.56
83.46

Postweight (kg)
90.71
69.85
67.13
71.21
83.91
70.76
61.23
52.65
69.85
86.63
76.2
64.86
76.2
82.1

TEE
(Kcal)
3642.91
2748.60
2896.32
3155.75
3735.23
3002.19
2818.07
2165.55
2890.53
3751.66
3209.54
2730.10
3330.44
3528.64

Older group
Subject Age
#
(years)
2
73
3
83
4
76
5
70
6
77
7
78
8
64
9
80
10
63
11
67
12
77
13
63
14
72
15
72

Sex
M
M
F
F
M
F
F
F
F
F
M
F
F
M

101

BMI
(kg/m2)
30.66
22.92
24.49
26.82
28.75
27.13
27.48
19.09
27.27
30.69
23.26
24.89
28.15
28.54

Heart rate variability data included in statistical analysis

Young
group

Older
group

subject
#

TP
(s2)

VLF
(s2)

LF
(s2)

2
3
4
5
7
9
12
13
14
15
16
17

pre
8.191
7.217
24.798
20.705
14.765
10.027
13.703
24.215
12.704
21.382
21.940
9.639

post
8.221
11.816
13.335
23.373
14.129
12.789
28.400
14.845
23.575
20.155
25.689
12.469

pre
5.600
4.790
15.831
13.823
9.746
6.801
8.684
16.093
8.149
13.737
13.741
6.623

post
5.662
7.693
8.605
14.837
9.525
8.693
18.409
10.014
15.710
12.336
16.721
8.311

pre
2.056
1.985
7.043
5.321
3.811
2.609
4.095
5.814
3.728
5.362
6.185
2.430

2
3
4
5
6
7
8
9
10
11
12
13
14
15

18.272
21.850
17.745
15.809
77.802
10.538
13.882
17.542
19.869
12.930
14.372
9.821
9.177
10.323

20.143
23.028
17.546
16.782
29.538
10.028
12.167
17.178
19.325
14.569
13.156
7.304
10.216
8.900

12.537
13.692
11.543
10.719
30.139
7.156
9.356
10.912
13.609
8.597
9.841
6.615
6.228
7.062

13.583
15.283
11.755
11.448
14.570
6.800
8.262
11.472
13.014
9.850
8.923
4.979
6.890
5.731

4.651
5.194
4.427
4.131
28.004
2.743
3.668
4.510
5.110
3.486
3.606
2.580
2.392
2.593
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HF
(s2)

post
2.078
3.129
3.552
6.386
3.556
3.241
7.036
3.854
6.104
4.615
6.941
3.334

pre
0.535
0.441
1.923
1.562
1.208
0.617
0.924
2.308
0.827
2.283
2.014
0.586

post
0.481
0.994
1.178
2.150
1.048
0.854
2.955
0.978
1.761
3.204
2.028
0.824

5.387
6.021
4.538
4.346
10.460
2.613
3.167
4.558
5.067
3.772
3.412
1.876
2.706
2.463

1.083
2.965
1.774
0.959
19.658
0.638
0.858
2.119
1.150
0.847
0.926
0.626
0.557
0.668

1.172
1.725
1.253
0.988
4.508
0.615
0.738
1.148
1.244
0.947
0.822
0.450
0.620
0.705

Heart rate variability data included in statistical analysis continued

Younger
group

Older
group

subject
#

LFnu
(nu)

HFnu
(nu)

LF/HF

2
3
4
5
7
9
12
13
14
15
16
17

pre
0.794
0.818
0.785
0.773
0.759
0.809
0.816
0.716
0.818
0.701
0.754
0.806

post
0.812
0.759
0.751
0.748
0.772
0.791
0.704
0.798
0.776
0.590
0.774
0.802

pre
0.206
0.182
0.215
0.227
0.241
0.191
0.184
0.284
0.182
0.299
0.246
0.194

post
0.188
0.241
0.249
0.252
0.228
0.209
0.296
0.202
0.224
0.410
0.226
0.198

pre
3.843
4.499
3.662
3.407
3.154
4.227
4.431
2.520
4.506
2.348
3.072
4.149

post
0.977
1.078
1.046
1.033
0.983
1.022
1.158
0.897
1.055
1.188
0.975
1.005

2
3
4
5
6
7
8
9
10
11
12
13
14
15

0.811
0.637
0.714
0.812
0.588
0.811
0.810
0.680
0.816
0.805
0.796
0.805
0.811
0.795

0.821
0.777
0.784
0.815
0.699
0.809
0.811
0.799
0.803
0.799
0.806
0.807
0.814
0.777

0.189
0.363
0.286
0.188
0.412
0.189
0.190
0.320
0.184
0.195
0.204
0.195
0.189
0.205

0.179
0.223
0.216
0.185
0.301
0.191
0.189
0.201
0.197
0.201
0.194
0.193
0.186
0.223

4.293
1.752
2.495
4.308
1.425
4.296
4.276
2.128
4.442
4.118
3.896
4.121
4.294
3.882

4.597
3.491
3.621
4.398
2.320
4.246
4.290
3.971
4.074
3.982
4.151
4.171
4.366
3.492
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Pulmonary function measures and MIP data

Young
group

Older
group

subject
#
2
3
4
5
7
9
12
13
14
15
16
17

pre
3.5
6.5
3.3
4.3
3.6
4.5
4.5
3.5
4.2
3.5
5.2
2.5

2
3
4
5
6
7
8
9
10
11
12
13
14
15

3.2
2.7
2.1
2.1
2.4
2
2.3
1.2
2.4
2.3
2.6
2.7
3
3.1

VC
(liter)

post
3.7
6.5
5.9
4.5
3.7
4.2
4.6
3.5
4.4
3.8
5.3
2.6

FEV1
(liter)
pre
post
3.2
3.4
5.1
5.3
3.2
3.9
3.8
3.7
1.8
2.8
3.3
3.5
4.2
4.4
3
3.2
3.9
4.2
2.6
2.7
4.2
4.3
2
2.3

MVV
( liter/min)
pre
post
99
127
179
234
147
209
137
142
152
162
116
135
205
233
113
122
135
166
110
115
174
192
110
115

MIP
(cmH2O)
pre
post
0.56
1.64
1.5
1.84
1.15
2.18
1.0z
1.31
0.86
1.65
1
1.76
1.56
2.22
0.46
0.79
0.98
1.78
1.36
1.96
1.27
1.54
0.98
1.44

2.8
2.9
1.9
1.8
2.8
2.1
2.3
2.1
2.5
2.6
3
3
3
3.3

2.6
2.3
1.7
1.6
2
1.6
1.8
1.1
2
2.1
2.2
2.2
2.5
2.6

114
103
66
77
90
53
85
71
98
94
98
101
118
126

0.44
0.46
0.56
0.83
1.14
0.53
0.99
0.43
0.82
0.54
0.68
0.93
0.6
1.12

2.3
2.4
1.6
1.4
2
1.5
1.8
1.7
2
2.5
2.5
2.4
2.5
2.6
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109
98
84
76
96
68
90
61
100
110
106
110
118
124

0.76
0.86
0.99
1.07
1.31
0.81
1.11
0.84
0.98
0.97
0.97
1.04
1.15
0.97

